<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version v40?><?ConverterInfo.XSLTName bmc2nlm.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neural Dev</journal-id><journal-title>Neural Development</journal-title><issn pub-type="epub">1749-8104</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1749-8104-4-33</article-id><article-id pub-id-type="pmid">19732411</article-id><article-id pub-id-type="doi">10.1186/1749-8104-4-33</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Jen</surname><given-names>Yi-Huei Linda</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yjen@uci.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Musacchio</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>michele@uci.edu</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Lander</surname><given-names>Arthur D</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>adlander@uci.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Developmental and Cell Biology, Developmental Biology Center and Center for Complex Biological Systems, University of California, Irvine, CA 92697-2300, USA</aff><aff id="I2"><label>2</label>Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697-3900, USA</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>4</day><month>9</month><year>2009</year></pub-date><volume>4</volume><fpage>33</fpage><lpage>33</lpage><ext-link ext-link-type="uri" xlink:href="http://www.neuraldevelopment.com/content/4/1/33"/><history><date date-type="received"><day>13</day><month>3</month><year>2009</year></date><date date-type="accepted"><day>4</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Jen et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Jen et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Jen Linda Yi-Huei yjen@uci.edu </dc:author><dc:title> Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Neural Development 4(1): 33-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1749-8104(2009)4:1&#x0003c;33&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1749-8104</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Cell surface heparan sulfate proteoglycans (HSPGs) act as co-receptors for multiple families of growth factors that regulate animal cell proliferation, differentiation and patterning. Elimination of heparan sulfate during brain development is known to produce severe structural abnormalities. Here we investigate the developmental role played by one particular HSPG, glypican-1 (Gpc1), which is especially abundant on neuronal cell membranes, and is the major HSPG of the adult rodent brain.</p></sec><sec><title>Results</title><p>Mice with a null mutation in <italic>Gpc1 </italic>were generated and found to be viable and fertile. The major phenotype associated with <italic>Gpc1 </italic>loss is a highly significant reduction in brain size, with only subtle effects on brain patterning (confined to the anterior cerebellum). The brain size difference emerges very early during neurogenesis (between embryonic days 8.5 and 9.5), and remains roughly constant throughout development and adulthood. By examining markers of different signaling pathways, and the differentiation behaviors of cells in the early embryonic brain, we infer that <italic>Gpc1</italic><sup>-/- </sup>phenotypes most likely result from a transient reduction in fibroblast growth factor (FGF) signaling. Through the analysis of compound mutants, we provide strong evidence that Fgf17 is the FGF family member through which Gpc1 controls brain size.</p></sec><sec><title>Conclusion</title><p>These data add to a growing literature that implicates the glypican family of HSPGs in organ size control. They also argue that, among heparan sulfate-dependent signaling molecules, FGFs are disproportionately sensitive to loss of HSPGs. Finally, because heterozygous <italic>Gpc1 </italic>mutant mice were found to have brain sizes half-way between homozygous and wild type, the data imply that endogenous HSPG levels quantitatively control growth factor signaling, a finding that is both novel and relevant to the general question of how the activities of co-receptors are exploited during development.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Cell surface heparan sulfate proteoglycans (HSPGs) have been implicated as key regulators of patterning and growth in animal development [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Participation in these events is generally thought to reflect their functions as co-receptors for diverse growth factor families, including fibroblast growth factors (FGFs), Wnts, Hedgehogs and bone morphogenetic proteins (BMPs) [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. In both vertebrates and invertebrates, disruption of heparan sulfate biosynthesis leads to severe, pervasive developmental abnormalities. For example, mice completely deficient in heparan sulfate arrest in gastrulation [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>In contrast, the elimination of the individual core proteins that carry cell surface heparan sulfate generally produces more subtle or tissue-restricted defects, particularly in mammals [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. Most likely this reflects the relatively large number of cell surface HSPGs (six glypicans and four syndecans in mammals), their overlapping patterns of expression, and a likelihood of functional redundancy that is made particularly high by the fact that carbohydrate moieties mediate much of their function. Despite such complexity, the analysis of core protein mutants has provided novel insights into at least some of the developmental and physiological processes in which HSPGs participate.</p><p>The glypicans define a structurally conserved family of glycosylphosphatidylinositol-anchored HSPGs that have been extensively studied for their roles in both development and cancer [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. Of the six glypicans in mammals, glypicans 1 and 2 (Gpc1 and Gpc2) were identified early on as major HSPGs of the developing brain [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. Subsequently, Gpc4 and Gpc5 were shown to be regionally expressed in the developing brain as well [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>]. Biochemical studies suggest that the most abundant glypican in the rodent brain, at least from late gestation onward, is Gpc1 [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. During development, <italic>Gpc1 </italic>is expressed in both neuroepithelial cells and mature neurons; it is particularly enriched in axons and nerve terminals [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. We reasoned, therefore, that loss of Gpc1 might produce defects in neurogenesis and/or axonal guidance, both of which are driven by growth factors regulated, in many cases, by HSPGs. As described below, the brains of mice rendered null for <italic>Gpc1 </italic>were morphologically normal, except for subtle mispatterning of the anterior cerebellum, but were abnormally small. Unexpectedly, we found that the reduction in brain size in mutant mice reflects a specific role for <italic>Gpc1 </italic>at the earliest stages of neurogenesis, before embryonic day (E)9.5.</p></sec><sec><title>Results</title><sec><title>Generation of glypican-1 null mice</title><p>Homologous recombination was used in embryonic stem (ES) cells to flank the first exon of <italic>Gpc1 </italic>- which includes the translational start site and signal sequence - with loxP sites, and successfully targeted cells were transiently transfected with Cre recombinase to induce excision (Figure <xref ref-type="fig" rid="F1">1A</xref>). Several independently excised ES clones were injected into C57BL/6 blastocysts to generate chimeric mice, one of which was extensively outcrossed to outbred (CD1; &#x02265;10 generations) and inbred (C57Bl/6; &#x02265;7 generations) mice (Figure <xref ref-type="fig" rid="F1">1B</xref>). This mutant allele (formally designated <italic>Gpc1</italic><sup>tm1 Alan</sup>) will be referred to here as <italic>Gpc1</italic><sup>-</sup>. A second allele - a gene trap insertion of <italic>LacZ </italic>into the fourth intron of Gpc1 - will be referred to as <italic>Gpc1</italic><sup><italic>LacZ</italic></sup>.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Targeted mutation of the Gpc1 locus creates a null allele</bold>. <bold>(A) </bold>Targeting strategy. A construct was created in which loxP sites flank exon 1 of <italic>Gpc1 </italic>and FLP recognition target (FRT) sites flank negative (<italic>TK</italic>) and positive (<italic>neo</italic>) selection markers. After transfection into embryonic stem (ES) cells, Southern blotting, using a probe located outside the targeted region, permitted verification of targeted integration. Transient tranfection of targeted ES cells with a Cre expression plasmid was then used to remove <italic>Gpc1 </italic>exon 1 and selection markers, prior to generation of mice. <bold>(B) </bold>Identification of the <italic>Gpc1 </italic>wild-type (+) and mutant (-) allele by PCR in mice. <bold>(C) </bold>Immunoblotting of adult brain membrane fractions with an anti-Gpc1 antibody. The presence of a discrete band found only in samples pretreated with heparitinase (Hase) demonstrates that the immunoreactive molecule is a heparan sulfate proteoglycan (HSPG) core protein. Note the decreased band intensity in heterozygous animals, and complete absence of immunoreactivity in homozygotes. The small apparent difference in mobility and slight tilt of the wild-type band is an artifact of uneven electrophoresis. <bold>(D) </bold>Immunoblotting of adult brain membrane HSPG core proteins using 3G10 antibody. Notice that the loss of a band at the correct molecular weight for Gpc1 in mutant animals is not accompanied by a substantial, consistent change in the presence of other HSPG cores. Hase, Heparitinase; Case, Condroitinase ABC. <bold>(E-G) </bold>Whole-mount <italic>in situ </italic>hybridization for <italic>Gpc1 </italic>at E8.5. Genotypes are as indicated. Red arrowheads point to areas of high Gpc1 expression in the developing brain and branchial arches. Notice that <italic>Gpc1 </italic>expression is greatly reduced or absent in homozygous mutants. Levels in heterozygotes are intermediate. <bold>(H, I) </bold>Whole-mount <italic>in situ </italic>hybridization for <italic>Gpc1 </italic>in wild-type (H) and <italic>Gpc1</italic><sup>-/- </sup>(I) embryos at E9.5. Staining has been deliberately overdeveloped to show the absence of signal in the mutant, suggesting that mutant <italic>Gpc1 </italic>mRNA is unstable. FB, forebrain; HB, hindbrain; MB, midbrain.</p></caption><graphic xlink:href="1749-8104-4-33-1"/></fig><p><italic>Gpc1</italic><sup>-/- </sup>and <italic>Gpc1</italic><sup><italic>LacZ</italic>/<italic>LacZ </italic></sup>mice were viable and fertile on outbred and inbred backgrounds, and appeared grossly normal. Biochemical studies revealed a complete absence of Gpc1 core protein from the brains of homozygous <italic>Gpc1</italic><sup>-/- </sup>animals, with intermediate levels in heterozygotes (Figure <xref ref-type="fig" rid="F1">1C,D</xref>). The expression of other brain heparan sulfate and chondroitin sulfate proteoglycans was not significantly affected (Figure <xref ref-type="fig" rid="F1">1D</xref>). Immunohistochemistry also demonstrated a loss of Gpc1 staining in both <italic>Gpc1</italic><sup>-/- </sup>and <italic>Gpc1</italic><sup><italic>LacZ</italic>/<italic>LacZ </italic></sup>mice (not shown). <italic>In situ </italic>hybridization studies, using both whole embryos and adult brain sections, also revealed a lack of <italic>Gpc1 </italic>transcripts in <italic>Gpc1</italic><sup>-/- </sup>animals (Figure <xref ref-type="fig" rid="F1">1E-I</xref>), suggesting that these animals are essentially protein- and message-null.</p></sec><sec><title>Loss of glypican-1 leads to reduced brain size and subtle patterning abnormalities of the cerebellum</title><p><italic>Gpc1</italic><sup>-/- </sup>mice were indistinguishable from wild type in gross appearance, size, lifespan, and a variety of simple behaviors (data not shown). Their internal anatomy appeared normal, with the exception of the brain, which was noticeably small (Figure <xref ref-type="fig" rid="F2">2A</xref>). On the CD1 background, adult <italic>Gpc1</italic><sup>-/- </sup>brains weighed 15.5 &#x000b1; 1.0% less than wild type, and <italic>Gpc1</italic><sup>-/+ </sup>brains weighed 7.8 &#x000b1; 1.0% less (Figure <xref ref-type="fig" rid="F2">2B</xref>). Both results were highly statistically significant, as variation in brain size among individuals within mouse strains is normally very small [<xref ref-type="bibr" rid="B37">37</xref>].</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Adult brain weight from Gpc1 null mutant is significantly reduced</bold>. <bold>(A) </bold>Dorsal views of freshly dissected adult brains. Note the apparent reduction in size of <italic>Gpc1</italic><sup>-/- </sup>brains. <bold>(B, C) </bold>Wet weights of fresh adult brains. <italic>Gpc1 </italic>genotypes are as indicated. There is a 15.5% decrease in brain weight in homozygous <italic>Gpc1 </italic>mutants (<italic>P </italic>&#x0003c; 0.0001); heterozygotes show an intermediate phenotype (7.8% decrease; * and **<italic>P </italic>&#x0003c; 0.0001). (B) N = 32 for +/+; 29 for +/-; 36 for -/-. Reduced brain weight is also observed in <italic>Gpc1</italic><sup><italic>LacZ </italic></sup>mutants. (C) N = 9 for +/+; 10 for <italic>LacZ</italic>/+; 7 for <italic>LacZ</italic>/<italic>LacZ</italic>. <bold>(D) </bold>Body weights of adult <italic>Gpc1 </italic>mutant and wild-type littermates, grouped by sex. No significant effect of genotype is observed. N = 23 for +/+; 30 for +/-; 37 for -/-. <bold>(E) </bold>Total DNA content of mutant and wild-type brains was measured as an indication of cell number. The data imply a 20% reduction in <italic>Gpc1</italic><sup>-/- </sup>brains. (*<italic>P </italic>&#x0003c; 0.001; N = 5 for +/+, and 5 for -/-).</p></caption><graphic xlink:href="1749-8104-4-33-2"/></fig><p>On a C57/Bl6 background, reductions in <italic>Gpc1</italic><sup>-/- </sup>and <italic>Gpc1</italic><sup>-/+ </sup>brain weight were also evident, but less pronounced (11% for <italic>Gpc1</italic><sup>-/-</sup>; data not shown), possibly reflecting the fact that wild-type C57/Bl6 brains are approximately 5% smaller than wild-type CD1 brains to begin with. As shown in Figure <xref ref-type="fig" rid="F2">2C</xref>, <italic>Gpc1</italic><sup><italic>LacZ</italic>/<italic>LacZ </italic></sup>mice also displayed reduced brain size (the higher variance of these data likely reflects the mixed CD1/C57 background of these animals). The brain weight reduction did not correlate with sex or body weight in Gpc1<sup>- </sup>or Gpc1<sup>LacZ </sup>mutant animals (Figure <xref ref-type="fig" rid="F2">2D</xref>).</p><p>To determine whether changes in brain size were due to the presence of fewer cells or smaller cells, DNA was extracted from whole brains and quantified using Hoechst 33258 fluorescence [<xref ref-type="bibr" rid="B38">38</xref>]. As shown in Figure <xref ref-type="fig" rid="F2">2E</xref>, <italic>Gpc1</italic><sup>-/- </sup>mice had about 20% less DNA per brain than their wild-type littermates. Thus, loss of <italic>Gpc1 </italic>leads to a 20% decrease in the number of brain cells.</p><p>Despite this, the shapes of <italic>Gpc1</italic><sup>-/- </sup>forebrains were morphometrically normal (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>), and most structures showed no apparent patterning defects. The major exception was found in the gyri of the cerebellar vermis, where the most anterior lobe (lobe I) either did not form or was rudimentary (Figure <xref ref-type="fig" rid="F3">3A-F</xref>). In addition, the primary fissure was shortened by 12%, with no significant change in the lengths of the other fissures, or in the overall cerebellar perimeter (data not shown). Notably, structures that are disrupted in heparan sulfate-deficient conditional <italic>Ext1 </italic>mutant mice, such as the interhemispheric commissures and the forebrain septum [<xref ref-type="bibr" rid="B39">39</xref>], were present in <italic>Gpc1 </italic>mutants (Figure <xref ref-type="fig" rid="F3">3G-J</xref>). In addition, no obvious changes in lamination of the cerebellar or cerebral cortices were observed (Figure <xref ref-type="fig" rid="F3">3K-N</xref>; and data not shown), and staining for markers of neuronal subpopulations, such as calbindin and parvalbumin, appeared normal (data not shown).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Cerebellar foliation defects in Gpc1 null mice</bold>. <bold>(A-F) </bold>Development of cerebellar foliation. Nissl-stained mid-sagittal sections are shown at postnatal days (P)0, 7 and 27. Lobes I to X are as marked in (H). As early as P7, a loss or severe reduction in folium one (red arrowhead) can be seen in <italic>Gpc1</italic><sup>-/- </sup>mice. <bold>(G-J) </bold>Forebrain anatomy. Coronal sections at the level of the hippocampus (G, H) and septum (I, J) show that midline commissural tracts appear normal in <italic>Gpc1</italic><sup>-/- </sup>mice. <bold>(K-N) </bold>Cerebellar lamination. Horizontal sections at P7 (K, L) and P27 (M, N) are shown. The appearance and thickness of the cellular and fiber tract layers are normal in <italic>Gpc1</italic><sup>-/- </sup>mice. CC, corpus callosum; EGL, external granular layer; HC, hipocampal commissure; IGL, internal granular layer; ML, molecular layer; PL, purkinje cell layer; S, septum. Bars in (F, H, J) = 1 mm.</p></caption><graphic xlink:href="1749-8104-4-33-3"/></fig></sec><sec><title>Brain size reduction reflects an early embryonic requirement for <italic>Gpc1</italic></title><p>Although Gpc1 has been reported to be the major HSPG of the adult brain [<xref ref-type="bibr" rid="B35">35</xref>], it is also expressed throughout development of the nervous system, and can be detected in neural tissue as early as head-fold stage (around E7) [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. We therefore measured brain size in <italic>Gpc1</italic><sup>-/- </sup>mice at various developmental stages. At birth, <italic>Gpc1</italic><sup>-/- </sup>brains weighed 15 to 20% less than wild-type brains, that is, they were smaller to about the same degree as seen in adulthood (data not shown). Prior to birth, weights could not be measured accurately given the small size of embryonic brains and the need to dissect under liquid; instead, volumes were estimated from photographic images of fresh embryos (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). As shown in Figure <xref ref-type="fig" rid="F4">4A-B</xref> the estimated volume of <italic>Gpc1</italic><sup>-/- </sup>brains was 22% below that of wild-type littermates as early as E9.5 (Figure <xref ref-type="fig" rid="F4">4B</xref>). In contrast, brain volumes measured one day earlier (E8.5) exhibited no difference between mutant and wild-type littermate embryos. Apparently, a phenotype of about the same magnitude as seen in adult animals emerges over the course of a single day of development.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>The <italic>Gpc1 </italic>mutant brain phenotype emerges early in neural development</bold>. <bold>(A) </bold>Lateral images of embryonic day (E)8.5, E9.5 and E11.5 wild-type (+/+) and <italic>Gpc1</italic><sup>-/- </sup>(-/-) embryos. Because the developmental stage of embryos is highly variable at E8.5 to E9.5, not every image is fully representative of the average for that genotype (for quantitative data, see (B, C) below). <bold>(B) </bold><italic>Gpc1</italic><sup>-/- </sup>embryos display smaller brains starting at E9.5. Brain size was estimated from photographic images, as described in Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>. Averages of estimated cranial area (at E8.5 and E9.5) and cranial volume (E11.5) were obtained for wild-type and homozygous mutant embryos in multiple litters (N = 23 for +/+ and N = 15 for -/- at E8.5; N = 25 for +/+ and N = 22 for -/- at E9.5; N = 10 for +/+ and N = 18 for -/- at E11.5). Units are pixels<sup>2 </sup>(&#x000d7; 10<sup>4</sup>) and pixels<sup>3 </sup>(&#x000d7; 10<sup>6</sup>) for area and volume measurements, respectively. Note the 14.1% decrease in area (* and **<italic>P </italic>&#x0003c; 0.05) that emerges at E9.5 (consistent with an approximately 20.4% decrease in volume). <bold>(C) </bold>Comparison of cranial area with somite number in E8.5 and E9.5 wild-type (+/+) and <italic>Gpc1</italic><sup>-/- </sup>(-/-) embryos. Linear regression lines demonstrate that, even when variation in somite number is controlled for, <italic>Gpc1</italic><sup>-/- </sup>brains are of normal size at E8.5, and abnormally small at E9.5. <bold>(D-F) </bold>Quantification of cell proliferation in the embryonic brain. Sagittal sections of E9.5 embryos were immunostained for phosphohistone H3 (PHH3) (D), counterstained with bizbenzamide (E) and the two images merged (F). Note the concentration of labeled cells along the pial and ventricular margins of the neuroepithelium (outlined). <bold>(G, H) </bold>Sets of serial sections were stained in this manner from multiple wild-type and <italic>Gpc1</italic><sup>-/- </sup>embryos at E8.5 (N = 5 for both +/+ and -/-), E9.5 (N = 8 for +/+ and N = 7 for -/-), and E11.5 (N = 7 for +/+ and N = 6 for -/-), and numbers of PHH3-labeled cells within the neuroepithelium were counted and normalized to neuroepithelial area for either the entire embryo (G) or the forebrain alone (H). The data show a statistically significant (*<italic>P </italic>&#x0003c; 0.001) decrease in PHH3-labeling index at E9.5, but no change at E11.5.</p></caption><graphic xlink:href="1749-8104-4-33-4"/></fig><p>To test whether the smaller brain size of E9.5 mutant embryos is a consequence of general developmental delay, we plotted brain size against somite number, a marker of developmental stage (Figure <xref ref-type="fig" rid="F4">4C</xref>). The data showed a slight trend - which was not statistically significant - toward <italic>Gpc1</italic><sup>-/- </sup>embryos being delayed by about 1 somite (at E8.5, wild type = 11.5 &#x000b1; 2.8 and mutant = 10.3 &#x000b1; 3.2; at E9.5, wild type = 22.0 &#x000b1; 2.4 and mutant = 21.2 &#x000b1; 2.4). Even taking such a trend into account, regression analysis showed that &#x0003e;70% of the brain size difference at E9.5 is independent of somite number (note the downward shift of the regression line at E9.5). These data suggest that, between E8.5 and E9.5, <italic>Gpc1 </italic>plays a specific and important role in nervous system growth.</p><p>To test whether that role involves regulation of cell proliferation, we used phospho-histone H3 immunohistochemistry to quantify the density of cells in M-phase (Figure <xref ref-type="fig" rid="F4">4D-H</xref>). If one considers the early central nervous system as a mass of cycling cells undergoing exponential expansion, with a typical cell cycle time of about 8 hours [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>], then in order to produce a 20% reduction in cell mass over the course of one day of development (and no further decrease thereafter), one would need to lengthen the cell cycle during that day by about 7%. Thus, in <italic>Gpc1</italic><sup>-/- </sup>embryos, we initially expected to see up to an approximately 7% decrease in mitotic labeling index at E8.5, followed by a return to normal on the following day.</p><p>Interestingly, we observed a larger and longer-lasting change in labeling index. For example, at E9.5, when we expected proliferation to have returned to wild-type levels, the labeling index in mutant brain neuroepithelium was decreased by 30% (Figure <xref ref-type="fig" rid="F4">4G</xref>; <italic>P </italic>&#x0003c; 0.001) The effect was specific to the neuroepithelial cells of these embryos (Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>), and did eventually disappear (by E11.5; Figure <xref ref-type="fig" rid="F4">4H</xref>). We considered the possibility that the larger-than expected drop in proliferation in <italic>Gpc1</italic><sup>-/- </sup>embryos was being offset by decreased cell death, but this was not supported by direct measurements. TUNEL staining showed that dying cells are not particularly abundant in the wild-type central nervous system at these stages, and if anything, displayed a trend (not statistically significant) toward being more abundant in the mutant, not less. A likely explanation for the delayed and larger-than-expected drop in neural labeling index became apparent later on, after more information about the probable mechanism of GPC1 action was obtained (see below).</p></sec><sec><title>Redundancy versus compensation within the glypican family</title><p>Six structurally similar glypicans are encoded by the mammalian genome. A possible explanation for the relatively mild phenotype in <italic>Gpc1</italic><sup>-/- </sup>mutants would be the participation of other glypicans in the regulation of early embryonic neural proliferation. In fact, <italic>Gpc2</italic>, <italic>Gpc</italic>3, <italic>Gpc4</italic>, <italic>Gpc</italic>5, and <italic>Gpc</italic>6 can all be detected in E8.5 and E9.5 embryos, although <italic>Gpc3 </italic>expression is excluded from most of the nervous system, and <italic>Gpc5 </italic>is not strongly expressed in brain until later stages (Figure <xref ref-type="fig" rid="F5">5A-E</xref>) [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Interestingly, the expression levels of Glypicans 2 to 6, as judged by whole mount <italic>in situ </italic>hybridization, were not noticeably altered in <italic>Gpc1</italic><sup>-/- </sup>mutants (Figure <xref ref-type="fig" rid="F5">5A-J</xref>), suggesting that there is little or no compensatory up-regulation of other glypicans in response to loss of <italic>Gpc1</italic>. Levels of <italic>Gpc4 </italic>RNA were also measured by quantitative RT-PCR and were unchanged in <italic>Gpc1</italic><sup>-/- </sup>mice (data not shown).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Influences of other glypicans on brain size regulation</bold>. <bold>(A-J) </bold>Whole-mount <italic>in situ </italic>hybridization for <italic>Gpc2</italic>, <italic>Gpc3</italic>, <italic>Gpc4</italic>, <italic>Gpc5 </italic>and <italic>Gpc6 </italic>in E9.5 wild-type (A-E) and <italic>Gpc1</italic><sup>-/- </sup>(F-J) mouse embryos suggests that there is no significant upregulation of other glypicans in response to <italic>Gpc1 </italic>loss. <bold>(K, L) </bold>Wet weights of fresh adult brains from allelic combinations of <italic>Gpc1</italic><sup>- </sup>with <italic>Gpc2</italic><sup>- </sup>(K) and <italic>Gpc1</italic><sup>- </sup>with <italic>Gpc4</italic><sup>lacZ </sup>(L). Genotypes are as indicated. The insertion site of the <italic>Gpc4</italic><sup>LacZ </sup>gene-trap allele has not been mapped, precluding development of an allele-specific PCR reaction to distinguish <italic>Gpc4</italic><sup>LacZ/+ </sup>from <italic>Gpc4</italic><sup>LacZ/LacZ </sup>animals. However, since <italic>Gpc4 </italic>is located on the X chromosome, males with a single LacZ allele are unambiguously hemizygous. Thus, the comparison in (L) is between wild-type (both sexes) and LacZ+ males. Note that <italic>Gpc2</italic><sup>-/- </sup>brains are not significantly different in size from wild type, nor does loss of <italic>Gpc2 </italic>enhance the phenotype of the <italic>Gpc1</italic><sup>-/- </sup>mouse. In contrast, the <italic>Gpc4</italic><sup>LacZ </sup>mutation significantly enhances the <italic>Gpc1</italic><sup>-/- </sup>phenotype (* and **<italic>P </italic>&#x0003c; 0.005). N = 7 for <italic>Gpc1</italic><sup>+/+</sup>;<italic>Gpc2</italic><sup>+/+</sup>, N = 5 for <italic>Gpc1</italic><sup>+/+</sup>;<italic>Gpc2</italic><sup>-/-</sup>, N = 3 for <italic>Gpc1</italic><sup>-/-</sup>;<italic>Gpc2</italic><sup>+/+</sup>, N = 3 for <italic>Gpc1</italic><sup>-/-</sup>;<italic>Gpc2</italic><sup>-/-</sup>, N = 2 for <italic>Gpc1</italic><sup>+/+</sup>;<italic>Gpc4</italic><sup>+/+ </sup>and N = 4 for Gpc1<sup>+/+</sup>;Gpc4<sup>+/<italic>Y</italic></sup>, N = 3 for <italic>Gpc1</italic><sup>-/-</sup>;<italic>Gpc4</italic><sup>+/+ </sup>and N = 8 for Gpc1<sup>-/-</sup>;Gpc4<sup>+/<italic>Y</italic></sup>, N = 14 for <italic>Gpc1</italic><sup>+/+</sup>;<italic>Gpc4</italic><sup>Lacz/Y</sup>, N = 9 for <italic>Gpc1</italic><sup>-/-</sup>;<italic>Gpc4</italic><sup>LacZ/Y</sup>.</p></caption><graphic xlink:href="1749-8104-4-33-5"/></fig><p>To test for redundancy between <italic>Gpc1 </italic>and the other glypicans that are expressed in early embryonic brain, we generated double mutants with <italic>Gpc2 </italic>and <italic>Gpc4 </italic>(mutants in <italic>Gpc6</italic>, the third glypican that is strongly expressed in early embryonic brain, have not yet been produced). For <italic>Gpc2 </italic>we used a targeted allele that, when homozygous, produces phenotypically normal mice with a complete loss of <italic>Gpc2 </italic>protein (S Saunders and ADL, unpublished data). As shown in Figure <xref ref-type="fig" rid="F5">5K</xref>, the brains of <italic>Gpc2</italic><sup>-/- </sup>mice are not reduced in size, and the brains of <italic>Gpc1</italic><sup>-/- </sup>;<italic>Gpc2</italic><sup>-/- </sup>double mutants are no smaller than those of <italic>Gpc1</italic><sup>-/- </sup>mice.</p><p>In contrast, when compound mutants were made between <italic>Gpc1 </italic>and a gene-trap allele of <italic>Gpc4 </italic>(<italic>Gpc4</italic><sup><italic>LacZ</italic></sup>), brain size appeared synergistically reduced (Figure <xref ref-type="fig" rid="F5">5L</xref>). This experiment may underestimate the contribution of Gpc4, since the <italic>Gpc4</italic><sup><italic>LacZ </italic></sup>allele is very likely not null (unpublished observations). Thus, within the limits of what can be assessed using existing mutants, <italic>Gpc1 </italic>appears to act redundantly with at least <italic>Gpc4 </italic>in controlling brain size.</p></sec><sec><title>Evidence for impairment of FGF signaling in the early <italic>Gpc1 </italic>mutant embryo</title><p>Numerous growth factor and morphogen signaling pathways have been implicated in the control of brain growth and development [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. Many of these pathways - including those mediated by Hedgehogs, Wnts, BMPs, and FGFs - are influenced by HSPGs in at least some developmental contexts [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. To screen for disruption of these pathways in <italic>Gpc1</italic><sup>-/- </sup>mice, we performed <italic>in situ </italic>hybridization at E8.5 and E9.5 for known downstream markers or reporter genes.</p><p>Although we saw no significant differences between wild-type and mutant embryos at these stages in the expression patterns of marker genes for Sonic hedgehog (Shh), BMP and Wnt signaling (Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>), the data suggested that FGF signaling was potentially attenuated. For one marker of FGF signaling - the mitogen-activated protein (MAP) kinase phosphatase <italic>Pyst1 </italic>(also known as <italic>Mkp3 </italic>and <italic>Dusp6</italic>) - we observed no significant change in the <italic>Gpc1</italic><sup>-/- </sup>mouse (Figure <xref ref-type="fig" rid="F6">6A-D</xref>), but for a second marker - <italic>Sprouty 2 </italic>(<italic>Spry2</italic>) - we noticed a consistent, yet transient, reduction in expression. Specifically, <italic>Spry2 in situ </italic>hybridization was consistently weaker in <italic>Gpc1</italic><sup>-/- </sup>brains at E8.5 to E9.5 (Figure <xref ref-type="fig" rid="F6">6E-H</xref>), but returned to a near-normal level by E10.25 (Additional file <xref ref-type="supplementary-material" rid="S5">5</xref>). To verify this result, we turned to quantitative RT-PCR. As shown in Figure <xref ref-type="fig" rid="F6">6I</xref>, there was a 40% reduction in <italic>Spry2 </italic>mRNA in <italic>Gpc1</italic><sup>-/- </sup>brains at E9.5, with some reduction in <italic>Spry1 </italic>mRNA (also a FGF target gene) as well. In contrast, and in agreement with the data from <italic>in situ </italic>hybridization, <italic>Pyst1 </italic>levels were unchanged.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Loss of Gpc1 results in weakened fibroblast growth factor (FGF) signaling and premature neuronal differentiation in brain</bold>. <bold>(A-D) </bold><italic>In situ </italic>hybridization for <italic>Pyst1</italic>. <bold>(E-H) </bold><italic>In situ </italic>hybridization for <italic>Sprouty 2 </italic>(<italic>Spry2</italic>). Both are markers of FGF signaling and only for <italic>Spry2 </italic>was a noticeable change observed between genotypes, with apparent reduced expression in <italic>Gpc1</italic><sup>-/- </sup>embryos at both embryonic day (E)8.5 and E9.5. <bold>(I) </bold>Real-time quantitative RT-PCR of <italic>Pyst1</italic>, <italic>Spry1 </italic>(a third FGF-target gene) and <italic>Spry2 </italic>from RNA isolated from E9.5 wild-type and <italic>Gpc1</italic><sup>-/- </sup>forebrains. The data imply a significant reduction (32.5%) in <italic>Spry2 </italic>message levels in the <italic>Gpc1 </italic>mutant (*<italic>P </italic>&#x0003c; 0.01), and a possible reduction in <italic>Spry1</italic>. <bold>(J) </bold>Erk enzymatic activity was measured by <italic>in vitro </italic>phosphorylation in E9.5 dorsal forebrain explants from <italic>Gpc1</italic><sup>+/+ </sup>and <italic>Gpc1</italic><sup>-/- </sup>embryos. Such explants display a high level of basal (unstimulated) Erk activity, presumably due to the actions of endogenous growth factors. Erk activity was found to be 41% lower in mutant tissue than in wild type (*<italic>P </italic>&#x0003c; 0.005; units are cpm &#x000d7; 10<sup>4</sup>). <bold>(K, L) </bold>Sagittal sections of E9.5 <italic>Gpc1</italic><sup>+/+ </sup>(K) and <italic>Gpc1</italic><sup>-/- </sup>(L) embryos were immunostained with Tuj1 (red), a marker for postmitotic neurons, and counterstained with the nuclear marker bizbenzamide (blue). <bold>(K', L') </bold>Enlarged images from white boxes in (K) and (L), corresponding to similar locations in the anterior midbrain. Note the greater density of Tuj1-positive cells in the mutant midbrain. White arrowheads in (K, L) point to the ventral forebrain, where virtually no Tuj1-positive cells are found in the wild-type, but several are present in the Gpc1<sup>-/- </sup>brain. <bold>(M, N) </bold>Numbers of Tuj1-positive cells within the forebrain (FB) and midbrain (MB) were totaled over serial sections of whole embryos at E8.5 (M) and E9.5 (N). Note the &#x0003e;2-fold increase in Tuj1-positive cells in <italic>Gpc1</italic><sup>-/- </sup>brains at E9.5. In contrast, no significant difference is observed at E8.5. At E9.5, N = 7 for +/+ and N = 4 for -/-; at E8.5, N = 4 for each genotype. *<italic>P </italic>&#x0003c; 0.005.</p></caption><graphic xlink:href="1749-8104-4-33-6"/></fig><p>To examine FGF signaling more directly, we produced short-term E9.5 dorsal forebrain explant cultures from wild-type and <italic>Gpc1</italic><sup>-/- </sup>embryos, and measured the enzymatic activity of extracellular regulated kinase (ERK) MAP kinase. As shown in Figure <xref ref-type="fig" rid="F6">6J</xref>, wild-type explants exhibited a high basal level of ERK activity, suggesting a high degree of endogenous growth factor signaling within the explant. In contrast, <italic>Gpc1</italic><sup>-/- </sup>explants exhibited 41% less ERK activity under the same conditions. In response to exogenous FGF2, wild-type explants displayed only a small additional increase in ERK activity, possibly because endogenous signaling was so high. We consistently observed that the exogenous FGF response was even lower in <italic>Gpc1</italic><sup>-/- </sup>explants, but due to the small size of the FGF effect we were unable to establish statistical significance for this conclusion (data not shown). Overall, the data strongly suggest that <italic>Gpc1 </italic>deficiency diminishes the response of cells of the early nervous system to FGFs.</p></sec><sec><title>Loss of glypican-1 results in premature differentiation of postmitotic neurons</title><p>It is widely reported that FGFs promote the proliferation of neural progenitor cells [<xref ref-type="bibr" rid="B50">50</xref>-<xref ref-type="bibr" rid="B59">59</xref>]. In most cases, FGFs appear not to act by affecting cell cycle kinetics, but by increasing the probability that the progeny of dividing cells remain in the cell cycle instead of differentiating (that is, FGFs suppress cell cycle exit). Such a mechanism of FGF action has been established, for example, in the cerebral cortex, the midbrain, the olfactory epithelium and the telencephalic subventricular zone [<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B58">58</xref>]. Indeed, even in non-neural tissues such as muscle, preventing cell cycle exit seems to be the central mode of action of FGF [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>].</p><p>If impairment of FGF signaling is the primary mechanism by which <italic>Gpc1 </italic>deficiency reduces brain size, we reasoned that <italic>Gpc1</italic>-deficient embryos should exhibit accelerated cell cycle exit and, as a consequence, premature neuronal differentiation. Indeed, this turned out to be the case. As shown in Figure <xref ref-type="fig" rid="F6">6K-N</xref>, higher than normal numbers of TuJ1+ neurons were detected in the brains of early <italic>Gpc1</italic><sup>-/- </sup>embryos. This effect was especially pronounced at E9.5, when there were over twice as many differentiated neurons in the fore- and midbrains of <italic>Gpc1 </italic>mutants as in wild-type animals (<italic>P </italic>&#x0003c; 0.005). To confirm that surplus TuJ1+ neurons were the progeny of cells that had recently undergone cell division, we pulsed embryos at E8.5 with the S-phase label 5-bromo-2'-deoxyuridine (BrdU), and one day later (E9.5) counted the number of TuJ1+/BrdU+ cells in the developing brain. In wild-type embryos we observed an average of 50 &#x000b1; 3 such cells per mm<sup>2</sup>, whereas in <italic>Gpc1</italic><sup>-/- </sup>embryos we observed three times as many (150 &#x000b1; 49; <italic>P </italic>&#x0003c; 0.05).</p><p>Not only do these results support the conclusion that FGF signaling is the main target of Gpc1 in the early central nervous system, they also explain the unexpectedly large, prolonged decreases in mitotic labeling index in <italic>Gpc1 </italic>mutant embryos (Figure <xref ref-type="fig" rid="F4">4G</xref>). This is because the labeling index represents the ratio of cells in M phase to total cells. When cells leave the cell cycle, they no longer affect the numerator of this ratio, but still contribute to its denominator, thereby causing an alteration in the labeling index that outlasts, for a period of time, any actual disturbance in the proliferative or differentiative behavior of cells (for a quantitative treatment of this point, see the Supplemental Appendix in Additional file <xref ref-type="supplementary-material" rid="S6">6</xref>). In short, the labeling index data in Figure <xref ref-type="fig" rid="F4">4G,H</xref> correspond well with the expected consequences of a temporary diminution in activity of a factor, such as FGF, that suppresses the differentiation of neuronal progenitors.</p></sec><sec><title>Glypican-1 acts through Fgf17</title><p>Several FGF family members have been implicated in brain development, with the subfamily formed by Fgf8, Fgf17 and Fgf18 having been shown to be especially important at early embryonic stages [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B62">62</xref>-<xref ref-type="bibr" rid="B64">64</xref>]. Fgf8, the most intensively studied of the group, plays critical roles in brain patterning and morphogenesis, and it has been suggested that some of the phenotypes in the <italic>Nes-Ext1</italic><sup><italic>null </italic></sup>brain are the result of impaired <italic>Fgf8 </italic>function [<xref ref-type="bibr" rid="B39">39</xref>]. However, there is substantial overlap in expression of all three of these Fgfs, which also share similar receptor binding properties, and are all thought to control neural proliferation [<xref ref-type="bibr" rid="B65">65</xref>-<xref ref-type="bibr" rid="B67">67</xref>].</p><p>In initial studies of compound mutants involving <italic>Gpc1</italic><sup>- </sup>and <italic>Fgf8</italic><sup><italic>neo </italic></sup>(a hypomorphic allele of Fgf8), we failed to observe significant genetic interaction (that is, a mutant allele of <italic>Fgf8 </italic>did not further reduce brain weight in a <italic>Gpc1 </italic>mutant; data not shown). In contrast, we were struck by similarities between the reported defects in anterior cerebellar patterning in <italic>Fgf17</italic><sup>-/- </sup>mice [<xref ref-type="bibr" rid="B66">66</xref>] and those reported here for <italic>Gpc1 </italic>mutants (Figure <xref ref-type="fig" rid="F3">3C-F</xref>). We therefore generated and analyzed a set of adult <italic>Gpc1</italic><sup>-</sup>;<italic>Fgf17</italic><sup>- </sup>compound mutants (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold><italic>Gpc1 </italic>phenotypes require <italic>Fgf17</italic></bold>. Compound <italic>Gpc1</italic>/<italic>Fgf17 </italic>genotypes were produced by interbreeding <italic>Gpc1</italic><sup>+/-</sup>;<italic>Fgf17</italic><sup>+/- </sup>mice. <bold>(A-E) </bold>Nissl-stained mid-sagittal sections through the cerebella of adult compound mutants. Red arrowheads mark the anterior-most lobe (lobe I), which disappears in both <italic>Gpc1</italic><sup>-/- </sup>and <italic>Fgf17</italic><sup>-/- </sup>animals. Red arrows mark the fusion of lobes III and IV, a phenotype observed in <italic>Fgf17</italic><sup>-/- </sup>mice. Note that the <italic>Gpc1</italic><sup>-/-</sup>;<italic>Fgf17</italic><sup>-/- </sup>phenotype is no more severe than the single <italic>Fgf17</italic><sup>-/- </sup>phenotype. <bold>(F) </bold>Fresh brain weights of adult compound mutants. Genotypes for each category are as indicated; 'N' refers to the number of animals obtained of each genotype. The data show that, on their own, the presence of either one or two copies of mutant alleles for either <italic>Gpc1 </italic>or <italic>Fgf17 </italic>progressively reduces brain size. When animals are null for Fgf17, the presence of mutant <italic>Gpc1 </italic>alleles has no significant effect (*<italic>P </italic>&#x0003c; 0.005; **<italic>P </italic>&#x0003c; 0.001; by Student's <italic>t</italic>-test).</p></caption><graphic xlink:href="1749-8104-4-33-7"/></fig><p>Representative midline cerebellar morphologies of animals of various compound genotypes are shown in Figure <xref ref-type="fig" rid="F7">7A-E</xref>. Figure <xref ref-type="fig" rid="F7">7F</xref> summarizes the distributions of brain weights among the entire collection, by genotype. The data clearly show that, as with <italic>Gpc1</italic>, loss of wild-type <italic>Fgf17 </italic>alleles leads to a progressive reduction in brain size and anterior cerebellar defects. Moreover, in animals that possessed either one or two functional <italic>Fgf17 </italic>alleles, the additional loss of one or two <italic>Gpc1 </italic>alleles led to a further reduction in brain size. However, in animals null for <italic>Fgf17</italic>, loss of <italic>Gpc1 </italic>had no significant phenotypic effect, either on brain size or cerebellar morphology. Complete dependence of the <italic>Gpc1 </italic>phenotype on the presence of a functional <italic>Fgf17 </italic>gene provides strong evidence that Fgf17 is, if not the only FGF through which Gpc1 acts, certainly among the most important, at least with respect to the control of brain size and cerebellar patterning.</p></sec></sec><sec><title>Discussion</title><p>The data presented here establish that Gpc1 plays a role in controlling brain size by regulating the behavior of progenitor cells during early brain development. Although the quantitative effect of Gpc1 loss is modest - a 20% decrease in cell number - it is highly significant when compared to normal variation in brain size within genetically homogeneous mice (Figure <xref ref-type="fig" rid="F2">2</xref>). The effect appears to be due to a shift in the balance of progenitor cell proliferation versus differentiation over the course of approximately one day of development - from E8.5 to E9.5 (Figures <xref ref-type="fig" rid="F4">4</xref> and <xref ref-type="fig" rid="F6">6</xref>). Diminished signaling by FGFs, but not other growth factors, could be demonstrated at around this time period in <italic>Gpc1</italic><sup>-/- </sup>mice (Figure <xref ref-type="fig" rid="F6">6</xref>). Genetic epistasis experiments strongly suggested that reduced Fgf17 signaling accounts for most or all of the <italic>Gpc1 </italic>mutant phenotypes observed here.</p><p>The transient and modest effects of <italic>Gpc1 </italic>loss raised the possibility of either compensation by, or redundancy with, other HSPGs, and although no evidence for compensatory up-regulation of other core proteins was obtained, studies with <italic>Gpc1</italic><sup>-</sup>;<italic>Gpc4</italic><sup>LacZ </sup>double mutants suggested that Gpc1 and Gpc4 may have at least partially overlapping functions in controlling brain size (Figure <xref ref-type="fig" rid="F5">5</xref>). This idea is lent further support by recent studies in <italic>Xenopus</italic>, in which morpholino-mediated knockdown of Gpc4 led to a reduction in size of dorsal forebrain structures [<xref ref-type="bibr" rid="B68">68</xref>].</p><p>It is noteworthy that <italic>Gpc1</italic><sup>-/- </sup>mice failed to display any of the severe developmental phenotypes reported for the <italic>Nestin1-Cre </italic>mediated conditional inactivation of <italic>Ext1</italic>, which produces a mouse in which all heparan sulfate is eliminated from the brain from about E10 onward. The phenotypes of the <italic>Nes1-Ext1</italic><sup><italic>null </italic></sup>mouse include specific hypoplasia of the cerebral hemispheres, absence of the cerebellum and olfactory bulbs, and loss of certain midline commissural tracts. It is possible that the mild deficits in the anterior cerebellum that we observed in the <italic>Gpc1</italic><sup>-/- </sup>mouse are related to the cerebellar agenesis seen in the <italic>Nes1-Ext1</italic><sup><italic>null </italic></sup>mouse. Interestingly, even when double mutant mice were made between <italic>Gpc1</italic><sup>- </sup>and <italic>Gpc4</italic><sup>LacZ </sup>(Figure <xref ref-type="fig" rid="F5">5</xref>), <italic>Gpc2</italic><sup>- </sup>(Figure <xref ref-type="fig" rid="F5">5</xref>) or <italic>Gpc5</italic><sup>- </sup>(YHJ, ADL and S Saunders, unpublished observations), <italic>Nes1-Ext1</italic><sup><italic>null </italic></sup>phenotypes were not observed. It may be that the combined loss of function of multiple glypicans, and/or glypicans as well as syndecans (the other major family of HSPGs), is required to substantially eliminate heparan sulfate function in brain development.</p><p>The growth factor families that have been shown to utilize HSPGs as co-receptors include FGFs, BMPs, Hedgehogs and Wnts [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B69">69</xref>-<xref ref-type="bibr" rid="B73">73</xref>] - all of which play important roles during early brain development [<xref ref-type="bibr" rid="B74">74</xref>-<xref ref-type="bibr" rid="B79">79</xref>]. It was surprising, therefore, that evidence only for reduced FGF signaling was obtained in the <italic>Gpc1</italic><sup>-/- </sup>mouse. Such evidence included reduced expression of FGF target genes, decreased basal Erk activation, and premature neuronal differentiation (Figure <xref ref-type="fig" rid="F6">6</xref>), as well as genetic epistasis between <italic>Gpc1 </italic>and <italic>Fgf17 </italic>(Figure <xref ref-type="fig" rid="F7">7</xref>). Several of the phenotypes in the <italic>Nes1-Ext1</italic><sup><italic>null </italic></sup>mouse are also consistent with reduced FGF signaling, including cerebellar and olfactory bulb agenesis and cerebral cortical hypoplasia [<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B80">80</xref>,<xref ref-type="bibr" rid="B81">81</xref>]. Diminished FGF signaling has also been implicated in the lens phenotypes in <italic>Ndst1 </italic>mutant mice (which produce aberrantly sulfated heparan sulfate [<xref ref-type="bibr" rid="B82">82</xref>,<xref ref-type="bibr" rid="B83">83</xref>]). These observations suggest that, <italic>in vivo</italic>, FGF signaling may be an especially sensitive indicator of deficits in HSPG function.</p><p>A fascinating aspect of the <italic>Gpc1 </italic>mutant phenotype is that the brain weight of heterozygous animals falls halfway between that of wild type and homozygous mutants (Figure <xref ref-type="fig" rid="F2">2</xref>). This implies that the amount of <italic>Gpc1 </italic>expressed by cells influences, in a continuous fashion, the level of growth factor signaling that cells perceive. In other words, Gpc1 may not merely be necessary for growth factor signaling, but a quantitative regulator of the 'gain' of signaling. Accordingly, regulation of Gpc1 expression may be an important part of the control circuitry that keeps brain size so tightly regulated in mammals [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B84">84</xref>].</p><p>Recent work suggests a similar quantitative role - albeit in the opposite direction - for <italic>Gpc3 </italic>[<xref ref-type="bibr" rid="B85">85</xref>]. Mouse <italic>Gpc3 </italic>mutants are known to display marked pre- and postnatal overgrowth of many organs, phenocopying Simpson Golabi Behmel syndrome (a syndrome caused by mutations in human GPC3 [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B86">86</xref>]). Because <italic>Gpc3 </italic>is on the X chromosome, gene dosage effects are not observable with null alleles, but studies of naturally occurring polymorphisms in the <italic>Gpc3 </italic>regulatory region have recently implied that quantitative variation in the level of <italic>Gpc3 </italic>expression directly (negatively) controls body size [<xref ref-type="bibr" rid="B85">85</xref>]. Even though the molecular mechanism of somatic growth inhibition by Gpc3 is likely to differ from the mechanism of brain growth promotion by Gpc1, the implication of both glypicans in quantitative regulation of size is striking. Intriguingly, a variety of studies in <italic>Drosophila </italic>also link invertebrate glypicans to organ size control [<xref ref-type="bibr" rid="B87">87</xref>-<xref ref-type="bibr" rid="B89">89</xref>].</p><p>The present study leaves unresolved the role that glypicans play in axons and nerve terminals, where Gpc1 and Gpc2 are especially abundant [<xref ref-type="bibr" rid="B36">36</xref>]. The absence of obvious defects in axonal pathways in the <italic>Gpc1</italic><sup>-/- </sup>mouse suggests that these molecules may play more of a role in synaptic physiology than in axonal growth or guidance. Certainly, evidence for the participation of syndecan-2 and syndecan-3 in synapse formation [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B90">90</xref>-<xref ref-type="bibr" rid="B92">92</xref>], as well as recent work on the <italic>Drosophila </italic>nervous system [<xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B93">93</xref>-<xref ref-type="bibr" rid="B95">95</xref>], suggests that HSPGs may play a variety of as yet unappreciated roles in basic neurophysiology. To this end, it is intriguing that recent genome-wide association studies in man have identified both GPC1 and FGFR2 (which encodes a major FGF receptor of the brain) as members of a small handful of genetic loci that correlate with risk of schizophrenia [<xref ref-type="bibr" rid="B96">96</xref>,<xref ref-type="bibr" rid="B97">97</xref>], a psychiatric disorder also associated with a small, but significant, reduction in brain volume [<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B99">99</xref>]. Clearly, a detailed behavioral and neurophysiological examination of the <italic>Gpc1 </italic>mutant mouse seems warranted in the future.</p></sec><sec><title>Conclusion</title><p>Cell-surface HSPGs are critical for growth and patterning in numerous tissues and organ systems, presumably as a consequence of their actions as growth factor co-receptors. Here we show that Gpc1 controls the size of the mammalian brain through an unexpectedly specific mechanism: regulation of the proliferation/differentiation behavior of progenitor cells during a very early stage of neurogenesis. We provide evidence that this action is mediated through regulation of Fgf17 signaling, and further show that Gpc1's effects are gene-dosage dependent. The data support the view that glypicans, and possibly HSPGs in general, serve as quantitative regulators of the gain of growth factor signaling during neural development.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Mice</title><p><italic>Gpc1</italic><sup>- </sup>heterozygous mutants were bred extensively onto CD1 and C57BL/6 backgrounds prior to breeding <italic>inter se </italic>to produce homozygous mutant animals. PCR primers specific for the <italic>Gpc1</italic><sup>- </sup>allele were 5'-AGCCGGCTTTTGTTGTCTC-3' and 5'-CACGAGTGTGCTAGGATAGGG-3'. Primers specific for the <italic>Gpc1 </italic>wild-type allele were 5'-CAGCGAAGTCCGCCAGAT-3' and 5'-CAGACCTCCCGAGTGCTAGG-3'.</p><p>The following additional mutant alleles were used in this study: gene-trap alleles of <italic>Gpc1 </italic>(GPC1lacZ; Baygenomics ID GST062 San Francisco, CA, USA) and <italic>Gpc4 </italic>(GPC4lacZ; Baygenomics ID Ex194) [<xref ref-type="bibr" rid="B100">100</xref>,<xref ref-type="bibr" rid="B101">101</xref>]; a targeted null mutation in <italic>Gpc2 </italic>(S Saunders and ADL, unpublished); <italic>Fgf2 </italic>(Jackson Laboratory, Bar Harbor, Maine, USA), a hypomorphic allele of <italic>Fgf8 </italic>(<italic>Fgf8</italic><sup><italic>neo </italic></sup>[<xref ref-type="bibr" rid="B102">102</xref>]), <italic>Fgf17 </italic>([<xref ref-type="bibr" rid="B74">74</xref>]) and a LacZ-reporter of canonical Wnt signaling (Bat-gal [<xref ref-type="bibr" rid="B103">103</xref>]). Wild type CD1 and C57BL/6 mice were from Charles River (San Diego, CA, USA) Genotypes were determined by PCR of tail DNA.</p><p>For production of staged embryos, timed matings were used and noon of the day of vaginal plug was considered as E0.5. At early embryonic stages, more precise staging was obtained from somite number. To obtain BrdU-labeled embryos, pregnant mice were injected intraperitoneally with 50 &#x003bc;g of BrdU (B5002; Sigma-Aldrich St. Louis, MO, USA)per gram body weight and embryos were collected 24 hours later.</p><p>Mouse colonies were maintained, and all animal experimentation conducted, in accordance with the policies and guidelines of the Institutional Animal Care and Use Committee (IACUC) of the University of California, Irvine. (IACUC protocol number 1998-1656).</p></sec><sec><title>Histology and histochemistry</title><p>Adult brains were fast-frozen in 2-methyl-butane prior to cryomicrotome sectioning at 20 &#x003bc;m. Embryos were dissected in cold phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde in PBS at 4&#x000b0;C overnight, cryoprotected in 30% sucrose in PBS at 4&#x000b0;C, and cryomicrotome sectioned at 10 to 20 &#x003bc;m. Sections were stored at -20&#x000b0;C prior to immunohistochemistry or Cresyl-Violet staining. For BrdU staining, cryosections were treated with 2 M HCl for 1 hour at 37&#x000b0;C. Sections were then blocked with 5% goat serum +10% bovine serum albumin/PBS +0.2% Tween20 and incubated with primary antibody diluted in blocking solution at 4&#x000b0;C overnight (anti-Gpc1 [<xref ref-type="bibr" rid="B27">27</xref>], 1:500; rabbit anti-phosphohistone H3 (anti-PHH3; Millipore, Billerica, MA, USA, 5 &#x003bc;g/ml, 1:500; Tuj1 (R&#x00026;D systems, 1:1,000, Minneapolis, MN, USA); anti-BrdU (Abcam, 1:100, Cambridge, MA, USA). Secondary antibodies (alexaFluor goat anti-rabbit IgG, 2 &#x003bc;g/ml alexaFluor goat anti-mouse IgG, 10 &#x003bc;g/ml; Cy3-goat anti mouse, 7 &#x003bc;g/ml (Jackson Immunoresearch, West Grove, PA, USA); or Cy2-goat anti rat, 14 &#x003bc;g/ml (Jackson Immunoresearch)) were applied for 1 hour at room temperature. For quantification of apoptosis, fluorescent TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assays (Apotag Kit, Serologicals, Norcross, GA, USA) were performed on cyrosections. Hoechst33258 was used at 2 &#x003bc;g/ml for nuclear counterstaining. Fluorescence images were analyzed with a Ziss Axiovert S100 microscope and Hamamatsu C4742-95 digital camera. Wholemount staining for beta-galactosidase activity was performed as described in [<xref ref-type="bibr" rid="B104">104</xref>].</p></sec><sec><title><italic>In situ </italic>hybridization</title><p>E8.5-E9.5 embryos, fixed by immersion in 4% paraformaldehyde, were gradually dehydrated in methanol and stored in 100% methanol at -20&#x000b0;C. Wholemount RNA <italic>in situ </italic>hybridization was performed as described [<xref ref-type="bibr" rid="B105">105</xref>] with probes synthesized using digoxigenin-labeled NTP mix (Roche, Indianapolis, IN, USA). Probes for glypicans (Glypicans 1 to 6) were obtained by RT-PCR from E13.5 brain total RNA, using the following primer pairs, and subcloned into the PCRII-TOPO vector (Invitrogen, Carlsbad, CA, USA): <italic>Gpc1</italic>, 5'-GCTACATCTCCATCTTCCTTGAC-3' and 5'-AACACACATTATCCACTGACACC-3'; <italic>Gpc2</italic>, 5'-AGTCTGGCGAGGGGTTAGAT-3' and 5'-GGCTACATTGAGGCAGAAGC-3'; <italic>Gpc3</italic>, 5'-GGATGGTGAAAGTGAAGAATCAAC-3' and 5'-GAGAGAAAGAGAAAAGAGGGAAAC-3'; <italic>Gpc4</italic>, 5'-CATGGCACGCTTAGGCTTGCTCGC-3' and 5'-TGGTTGCACTGTTCGCTGACCACG-3'; <italic>Gpc5</italic>, 5'-CGCCAGGATGTTAGTCCATT-3' and 5'-AATTTCTGCCCATTGAGGTG-3'; <italic>Gpc6</italic>, 5'-GCTGTGTATTCTTGCTCTCTCCGGG-3' and 5'-GTACAGCATCCCGTAGGTCCGGAC-3'.</p><p>The following additional RNA probes were used: <italic>Pax6 </italic>(335 to 595 bp MN_013627), <italic>Spry2 </italic>(probe used in [<xref ref-type="bibr" rid="B106">106</xref>]), <italic>Pyst1 </italic>(probe used in [<xref ref-type="bibr" rid="B107">107</xref>]), <italic>Ptc1 </italic>(probe used in [<xref ref-type="bibr" rid="B108">108</xref>]), <italic>Msx1 </italic>(<italic>Eco</italic>RI fragment from IMAGE clone 903377). Controls for <italic>in situ </italic>hybridization consisted of sense probes derived from the same DNA fragments.</p></sec><sec><title>Measurement of brain size and DNA content</title><p>Postnatal and adult brains were freshly dissected. After removal of olfactory bulbs and remaining spinal cord (at the level of the posterior margin of the cerebellum), brains were immediately weighed on a laboratory scale.</p><p>Images of fresh embryos were collected using a Leica MZFLIII stereomicroscope and a SPOT camera (Diagnostic Instruments, Inc. Sterling Heights, MI, USA). For embryos at E11.5 or older, brain height, depth and width were separately measured from lateral and frontal images (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>), and multiplied to produce a volume estimate. For E8.5 and E9.5 embryos, measurements of area were obtained from perimeter tracings of lateral views using Image J analysis software [<xref ref-type="bibr" rid="B109">109</xref>]. At these stages the central nervous system comprises the majority of head tissue, so such tracings included the entire head, stopping ventrally at the rostral border of the first branchial arch, and dorsally at the top of mesencephalon. Volume was then estimated as area<sup>3/2</sup>. In some cases, volume was also estimated by the procedures outlined above for older embryos, and qualitatively similar results were obtained.</p><p>DNA content in brain homogenates was measured by enhancement of bisbenzimid fluorescence at 458 nm, as described by Labarca and Paigen [<xref ref-type="bibr" rid="B38">38</xref>]. A linear standard curve (1 to 10 &#x003bc;g/ml) was obtained using salmon sperm DNA (Invitrogen).</p></sec><sec><title>Quantitative RT-PCR</title><p>Forebrain vesicles of E9.5 and E8.5 wild-type and mutant mice were dissected in ice-cold PBS, and RNA was isolated and column purified (Aurum Total RNA Mini Kit, Bio-Rad, Herculeus, CA, USA) according to the manufacturer's instructions. cDNA was generated by reverse transcription with a mixture of oligo dT and random hexamers (Superscript First-Strand Synthesis kit, Invitrogen). PCR quality controls, experimental runs and statistical methods were performed as described [<xref ref-type="bibr" rid="B110">110</xref>,<xref ref-type="bibr" rid="B111">111</xref>]. Quantification of total mRNA expression was performed with an Opticon System (MJ Systems CFD-3200, Calgary, Denver, USA) and SYBR-Green (Bio-Rad).</p><p>All measurements were normalized to values for 18S RNA in the same samples. All cDNA samples were validated for reverse transcription reaction efficiency and minimal genomic DNA contamination (cDNA/genomic target ratio &#x0003e;10<sup>5</sup>) for 40 cycles in duplicates. Average of duplicated cycle threshold (Ct) values were normalized as &#x00394;Ct (Ct<sub>gene of interest </sub>- Ct<sub>reference(18S)</sub>). Relative levels were converted using the 2<sup>-&#x00394;&#x00394;Ct </sup>method: &#x00394;&#x00394;Ct = &#x00394;Ct<sub>mutant </sub>- &#x00394;Ct<sub>wild-type </sub>[<xref ref-type="bibr" rid="B112">112</xref>] Averages of duplicate Ct, normalized &#x00394;Ct, &#x00394;&#x00394;Ct and relative level 2<sup>-&#x00394;&#x00394;Ct </sup>and standard errors were calculated using Microsoft Excel.</p></sec><sec><title>Measurement of Erk activity in embryonic explant cultures</title><p>E9.5 dorsal telencephalon explants were isolated and cultured as previously described [<xref ref-type="bibr" rid="B110">110</xref>]. After 1 hour of incubation at 37&#x000b0;C, FGF2 (R&#x00026;D Systems) was added at the concentrations indicated for 15 minutes. Explants were briefly washed with 1&#x000d7; PBS and individually homogenized in lysis buffer (1 mM EGTA, 1% Triton X-100, 150 mM NaCl, 50 mM Tris-Cl pH7.4, 1% NP40, 1 &#x003bc;g/ml phenylmethylsulphonyl fluoride (PMSF), 1 &#x003bc;g/ml leupeptin, 1 &#x003bc;g/ml pepstatin, 1 &#x003bc;g/ml aprotinin, 25 &#x003bc;g/ml N-ethylmaleimide (NEM), and phosphatase inhibitors (1 mM NaF, 1 mM Na<sub>3</sub>VO<sub>4</sub>)) with a disposable pestle (Knotes Scientific, Vineland, NJ, USA) Lysed samples were stored at -80&#x000b0;C until use. Erk activity was quantified using an <italic>in vitro </italic>phosphorylation assay (MAP Kinase/Erk Assay kit; Upstate Biotechnology) following the manufacturer's instructions, with or without the 20 &#x003bc;M Erk inhibitor FR180204 (Calbiochem, Gibbstownm, NJ, USA) treatment for 10 minutes prior to the assay. Values in the presence of FR180204 were taken to represent non-ERK phosphorylation activity, and subtracted from each data point. Data were normalized to protein concentration determined by a bicinchoninic acid (BCA) assay [<xref ref-type="bibr" rid="B113">113</xref>].</p></sec><sec><title>Subcellular fractionation and analysis of proteoglycan content</title><p>Adult brains were dissected in ice-cold PBS and immediately homogenized. to obtain membrane and soluble fractions as described [<xref ref-type="bibr" rid="B114">114</xref>]. For SDS-PAGE analysis, samples prepared in this way were digested for 30 minutes at 37&#x000b0;C with Heparinase III or with Heparinase III plus Chondroitinase ABC (all used at 1.5 U/mg of protein; both enzymes were purchased from Seikagaku Corp., Tokyo, Japan) along with a proteinase inhibitor mixture (10 &#x003bc;g/ml pepstatin A, 20 &#x003bc;g/ml leupeptin, 2.5 mg/ml NEM, and PMSF in 50 mM Tris-hydroxyaminomethane, 15 mM phosphoric acid, pH7.3). Digested samples were boiled for 10 minutes in SDS-PAGE sample buffer and loaded at 50 &#x003bc;g protein per lane onto 7.5% SDS-polyacrylamide gels, and subjected to electrophoresis. Gels were transferred to PVDF membrane (Millipore, Billerica, MA, USA) and probed with rabbit anti-glypican-1 (1:3,000) antibody or mouse 3G10 monoclonal antibody (1:2,000; USBiological, Swampscott, MA, USA). Samples without enzyme treatment, or subjected to single enzyme treatment, were used where indicated. Blots were incubated with horseradish peroxidase-conjugated goat anti-rabbit or donkey anti-mouse antibody, as appropriate, and visualized using enhanced chemiluminescence.</p></sec></sec><sec><title>Abbreviations</title><p>BMP: bone morphogenetic protein; BrdU: 5-bromo-2'-deoxyuridine; E: embryonic day; ERK: extracellular regulated kinase; ES: embryonic stem; FGF: fibroblast growth factor; Gpc: glypican; HSPG: heparan sulfate proteoglycan; MAP: mitogen-activated protein; NEM: N-ethylmaleimide; <italic>Spry</italic>: <italic>Sprouty</italic>; PBS: phosphate-buffered saline; PHH3: phosphohistone H3; PMSF: phenylmethylsulphonyl fluoride.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>YHJ and ADL conceived of the studies, designed the experiments, interpreted the data and wrote the manuscript. YHJ carried out the experiments, except for the generation of <italic>Gpc1 </italic>knockout mice, which was carried out by MM.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Morphometric comparison of wild-type and <italic>Gpc1</italic><sup>-/- </sup>forebrains</bold>. Freshly dissected adult brains were photographed from the dorsal surface. Tracings of the outline of the forebrain hemispheres were digitized and each curve converted to a series of points, in intervals of 0.03 radians, on a polar plot centered on its centroid. For each genotype, the curves from different brains were overlayed and rotated so that the medial edges of each tracing (which are relatively straight) were optimally aligned. <bold>(A) </bold>An example from the right hemisphere of nine mutant mice. An average curve was generated by calculating the average distance from the centroid for the family of curves at each angular position. <bold>(B) </bold>Curves representing one standard deviation above and below the average were similarly produced. <bold>(C) </bold>A single curve depicting the ratio of the average mutant and wild-type values at each angular position was then generated, and error bars around this curve were calculated from the square root of the sum of the squares of the relative errors (standard deviation/mean) for the two mutant and wild-type average curves; the comparison of nine mutant and four wild-type right hemispheres using this process is shown. The null hypothesis - that mutant and wild-type forebrains are identical in shape - implies that the ratio curve should be a perfect circle (that is, distance to the centroid for mutant and wild-type should differ by the same proportion at every angular position). As shown in (C), a circle (r = 0.937) fit within the error bars at every angular position, implying that mutant forebrains are approximately 6.3% smaller in linear dimension, with no significant difference in forebrain shape. Note that a 6.3% decrease in linear dimension is consistent with an 18% decrease in volume, comparable to the observed 15.5% decrease in total brain weight (Figure <xref ref-type="fig" rid="F2">2</xref>).</p></caption><media xlink:href="1749-8104-4-33-S1.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Approaches used for estimation of brain volumes of embryos</bold>. Approaches used for estimation of brain volumes of <bold>(A) </bold>E8.5, <bold>(B) </bold>E9.5 and <bold>(C) </bold>E11.5 embryos. Outlines of the primarily neural regions of the head were traced on lateral images of E8.5 to E9.5 embryos, and the enclosed area calculated. At E11.5, separate measurements were made of depth (green line in (C), running from the midbrain-hindbrain boundary (MHB) to the upper nasal-facial junction), height (blue line in (C) connecting the midbrain-forebrain boundary (MFB) to the upper jaw), and width (interocular distance, measured from a frontal view; not shown).</p></caption><media xlink:href="1749-8104-4-33-S2.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p><bold>Evaluation of cell proliferation in wild-type (+/+) and Gpc1 mutant (-/-) embryos at E9.5</bold>. <bold>(A-F) </bold>Sagittal sections of E9.5 embryos were immunostained for phosphohistone H3 (PHH3) (A, D), counterstained with bizbenzamide (B, E) and the two images merged (C,F). As quantified in Figure <xref ref-type="fig" rid="F4">4G,H</xref>, there are fewer PHH3 labeled cells in the <italic>Gpc1</italic><sup>-/-</sup>neuroepithelium than in the wild type. <bold>(G) </bold>However, as shown here, the PHH3 labeling index specifically in non-neuroepithelial areas of the head is not significantly different between <italic>Gpc1</italic><sup>-/- </sup>and wild-type embryos.</p></caption><media xlink:href="1749-8104-4-33-S3.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional file 4</title><p><bold>Lack of apparent difference in Sonic hedgehog, BMP and Wnt signal intensity in <italic>Gpc1</italic><sup>-/- </sup>during early stages of brain development</bold>. <bold>(A-J) </bold>Whole mount <italic>in situ </italic>hybridization and reporter gene expression in E8.5 and E9.5 wild type (+/+) and <italic>Gpc1</italic><sup>-/- </sup>(-/-) embryos were used to assess levels and distribution of activity of the Hedgehog, BMP and Wnt signaling pathways, all of which have been reported to be influenced by HSPGs. (A-D) <italic>In situ </italic>hybridization for <italic>Patched1</italic>, a marker of Hedgehog signaling. (E-H) <italic>In situ </italic>hybridization for <italic>Msx1</italic>, a marker for BMP signaling. Those small differences in staining intensity that are visible in these images (for example, in the anterior hindbrain) were not consistent findings, but reflect a high degree of embryo-to-embryo variability in <italic>Msx1 </italic>whole mount <italic>in situ </italic>hybridization. (I-J) &#x003b2;-galactosidase activity in embryos crossed onto a BAT-gal background, in which LacZ expression reports canonical Wnt signaling.</p></caption><media xlink:href="1749-8104-4-33-S4.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S5"><caption><title>Additional file 5</title><p><bold>Whole mount <italic>in situ </italic>hybridization for <italic>Spry2 </italic>at E10.25</bold>. When compared with Figure <xref ref-type="fig" rid="F6">6E-H</xref>, the data suggest that <italic>Spry2 </italic>expression returns to near-normal in <italic>Gpc1</italic><sup>-/- </sup>embryos by E10.25. These observations are consistent with the view that the disruption of Fgf signaling in <italic>Gpc1</italic><sup>-/- </sup>embryos is transient.</p></caption><media xlink:href="1749-8104-4-33-S5.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S6"><caption><title>Additional file 6</title><p><bold>Supplemental appendix: models for the effect of Gpc1 deficiency on early brain development</bold>. Supplemental appendix: models for the effect of Gpc1 deficiency on early brain development</p></caption><media xlink:href="1749-8104-4-33-S6.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Felix Truong, Betty Yeh, and Karishima Datye for their excellent technical assistance and Edwin Monuki and Spencer Currle for their assistance in setting up forebrain explant and quantitative PCR assays. We thank David Ornitz for providing <italic>Fgf17 </italic>mice, Anne Calof for providing <italic>Fgf8</italic><sup>neo </sup>mice, Maike Sander for BAT-gal mice, and William Skarnes for <italic>Gpc1</italic><sup>LacZ </sup>and <italic>Gpc4</italic><sup>LacZ </sup>mice. This work was supported by NIH grants R01-NS26862 and P50-GM076516.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X</given-names></name></person-group><article-title>Functions of heparan sulfate proteoglycans in cell signaling during development</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>6009</fpage><lpage>6021</lpage><pub-id pub-id-type="pmid">15563523</pub-id><pub-id pub-id-type="doi">10.1242/dev.01522</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>Specificities of heparan sulphate proteoglycans in developmental processes</article-title><source>Nature</source><year>2000</year><volume>404</volume><fpage>725</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">10783877</pub-id><pub-id pub-id-type="doi">10.1038/35008000</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>J</given-names></name></person-group><article-title>Messages in the matrix: proteoglycans go the distance</article-title><source>Dev Cell</source><year>2007</year><volume>13</volume><fpage>166</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">17681128</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2007.07.015</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baeg</surname><given-names>GH</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Khare</surname><given-names>N</given-names></name><name><surname>Baumgartner</surname><given-names>S</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11092814</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carrasco</surname><given-names>H</given-names></name><name><surname>Olivares</surname><given-names>GH</given-names></name><name><surname>Faunes</surname><given-names>F</given-names></name><name><surname>Oliva</surname><given-names>C</given-names></name><name><surname>Larrain</surname><given-names>J</given-names></name></person-group><article-title>Heparan sulfate proteoglycans exert positive and negative effects in Shh activity</article-title><source>J Cell Biochem</source><year>2005</year><volume>96</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">16149075</pub-id><pub-id pub-id-type="doi">10.1002/jcb.20586</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paine-Saunders</surname><given-names>S</given-names></name><name><surname>Viviano</surname><given-names>BL</given-names></name><name><surname>Economides</surname><given-names>AN</given-names></name><name><surname>Saunders</surname><given-names>S</given-names></name></person-group><article-title>Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>2089</fpage><lpage>2096</lpage><pub-id pub-id-type="pmid">11706034</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M109151200</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stickens</surname><given-names>D</given-names></name><name><surname>Zak</surname><given-names>BM</given-names></name><name><surname>Rougier</surname><given-names>N</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><article-title>Mice deficient in Ext2 lack heparan sulfate and develop exostoses</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>5055</fpage><lpage>5068</lpage><pub-id pub-id-type="pmid">16236767</pub-id><pub-id pub-id-type="doi">10.1242/dev.02088</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paine-Saunders</surname><given-names>S</given-names></name><name><surname>Viviano</surname><given-names>BL</given-names></name><name><surname>Zupicich</surname><given-names>J</given-names></name><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Saunders</surname><given-names>S</given-names></name></person-group><article-title>glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development</article-title><source>Dev Biol</source><year>2000</year><volume>225</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">10964473</pub-id><pub-id pub-id-type="doi">10.1006/dbio.2000.9831</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cano-Gauci</surname><given-names>DF</given-names></name><name><surname>Song</surname><given-names>HH</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>McKerlie</surname><given-names>C</given-names></name><name><surname>Choo</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Pullano</surname><given-names>R</given-names></name><name><surname>Piscione</surname><given-names>TD</given-names></name><name><surname>Grisaru</surname><given-names>S</given-names></name><name><surname>Soon</surname><given-names>S</given-names></name><name><surname>Sedlackova</surname><given-names>L</given-names></name><name><surname>Tanswell</surname><given-names>AK</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name><name><surname>Yeger</surname><given-names>H</given-names></name><name><surname>Lockwood</surname><given-names>GA</given-names></name><name><surname>Rosenblum</surname><given-names>ND</given-names></name><name><surname>Filmus</surname><given-names>J</given-names></name></person-group><article-title>Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome</article-title><source>J Cell Biol</source><year>1999</year><volume>146</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">10402475</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stepp</surname><given-names>MA</given-names></name><name><surname>Gibson</surname><given-names>HE</given-names></name><name><surname>Gala</surname><given-names>PH</given-names></name><name><surname>Iglesia</surname><given-names>DD</given-names></name><name><surname>Pajoohesh-Ganji</surname><given-names>A</given-names></name><name><surname>Pal-Ghosh</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Aquino</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>AM</given-names></name><name><surname>Goldberger</surname><given-names>O</given-names></name><name><surname>Hinkes</surname><given-names>MT</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse</article-title><source>J Cell Sci</source><year>2002</year><volume>115</volume><fpage>4517</fpage><lpage>4531</lpage><pub-id pub-id-type="pmid">12414997</pub-id><pub-id pub-id-type="doi">10.1242/jcs.00128</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotte</surname><given-names>M</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name><name><surname>Joussen</surname><given-names>AM</given-names></name></person-group><article-title>Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps</article-title><source>Curr Eye Res</source><year>2005</year><volume>30</volume><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">16020273</pub-id><pub-id pub-id-type="doi">10.1080/02713680590956289</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotte</surname><given-names>M</given-names></name><name><surname>Joussen</surname><given-names>AM</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Andre</surname><given-names>P</given-names></name><name><surname>Wagner</surname><given-names>DD</given-names></name><name><surname>Hinkes</surname><given-names>MT</given-names></name><name><surname>Kirchhof</surname><given-names>B</given-names></name><name><surname>Adamis</surname><given-names>AP</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>1135</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">11923257</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reizes</surname><given-names>O</given-names></name><name><surname>Lincecum</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Goldberger</surname><given-names>O</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Kaksonen</surname><given-names>M</given-names></name><name><surname>Ahima</surname><given-names>R</given-names></name><name><surname>Hinkes</surname><given-names>MT</given-names></name><name><surname>Barsh</surname><given-names>GS</given-names></name><name><surname>Rauvala</surname><given-names>H</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3</article-title><source>Cell</source><year>2001</year><volume>106</volume><fpage>105</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">11461706</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00415-9</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaksonen</surname><given-names>M</given-names></name><name><surname>Pavlov</surname><given-names>I</given-names></name><name><surname>Voikar</surname><given-names>V</given-names></name><name><surname>Lauri</surname><given-names>SE</given-names></name><name><surname>Hienola</surname><given-names>A</given-names></name><name><surname>Riekki</surname><given-names>R</given-names></name><name><surname>Lakso</surname><given-names>M</given-names></name><name><surname>Taira</surname><given-names>T</given-names></name><name><surname>Rauvala</surname><given-names>H</given-names></name></person-group><article-title>Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory</article-title><source>Mol Cell Neurosci</source><year>2002</year><volume>21</volume><fpage>158</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">12359158</pub-id><pub-id pub-id-type="doi">10.1006/mcne.2002.1167</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Echtermeyer</surname><given-names>F</given-names></name><name><surname>Streit</surname><given-names>M</given-names></name><name><surname>Wilcox-Adelman</surname><given-names>S</given-names></name><name><surname>Saoncella</surname><given-names>S</given-names></name><name><surname>Denhez</surname><given-names>F</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name><name><surname>Goetinck</surname><given-names>P</given-names></name></person-group><article-title>Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4</article-title><source>J Clin Invest</source><year>2001</year><volume>107</volume><fpage>R9</fpage><lpage>R14</lpage><pub-id pub-id-type="pmid">11160142</pub-id><pub-id pub-id-type="doi">10.1172/JCI10559</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilcox-Adelman</surname><given-names>SA</given-names></name><name><surname>Denhez</surname><given-names>F</given-names></name><name><surname>Goetinck</surname><given-names>PF</given-names></name></person-group><article-title>Syndecan-4 modulates focal adhesion kinase phosphorylation</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>32970</fpage><lpage>32977</lpage><pub-id pub-id-type="pmid">12087088</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M201283200</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stringer</surname><given-names>SE</given-names></name><name><surname>Gallagher</surname><given-names>JT</given-names></name></person-group><article-title>Heparan sulphate</article-title><source>Int J Biochem Cell Biol</source><year>1997</year><volume>29</volume><fpage>709</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">9251237</pub-id><pub-id pub-id-type="doi">10.1016/S1357-2725(96)00170-7</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>G</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>The emerging roles of cell surface heparan sulfate proteoglycans</article-title><source>Matrix Biol</source><year>1998</year><volume>17</volume><fpage>461</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">9881596</pub-id><pub-id pub-id-type="doi">10.1016/S0945-053X(98)90092-0</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>CM</given-names></name><name><surname>Reichsman</surname><given-names>F</given-names></name><name><surname>Hinkes</surname><given-names>MT</given-names></name><name><surname>Lincecum</surname><given-names>J</given-names></name><name><surname>Becker</surname><given-names>KA</given-names></name><name><surname>Cumberledge</surname><given-names>S</given-names></name><name><surname>Bernfield</surname><given-names>M</given-names></name></person-group><article-title>Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>329</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">10888884</pub-id><pub-id pub-id-type="doi">10.1038/77108</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blackhall</surname><given-names>FH</given-names></name><name><surname>Merry</surname><given-names>CL</given-names></name><name><surname>Davies</surname><given-names>EJ</given-names></name><name><surname>Jayson</surname><given-names>GC</given-names></name></person-group><article-title>Heparan sulfate proteoglycans and cancer</article-title><source>Br J Cancer</source><year>2001</year><volume>85</volume><fpage>1094</fpage><lpage>1098</lpage><pub-id pub-id-type="pmid">11710818</pub-id><pub-id pub-id-type="doi">10.1054/bjoc.2001.2054</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Cat</surname><given-names>B</given-names></name><name><surname>David</surname><given-names>G</given-names></name></person-group><article-title>Developmental roles of the glypicans</article-title><source>Semin Cell Dev Biol</source><year>2001</year><volume>12</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">11292377</pub-id><pub-id pub-id-type="doi">10.1006/scdb.2000.0240</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filmus</surname><given-names>J</given-names></name><name><surname>Selleck</surname><given-names>SB</given-names></name></person-group><article-title>Glypicans: proteoglycans with a surprise</article-title><source>J Clin Invest</source><year>2001</year><volume>108</volume><fpage>497</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">11518720</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>HH</given-names></name><name><surname>Filmus</surname><given-names>J</given-names></name></person-group><article-title>The role of glypicans in mammalian development</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1573</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">12417406</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>KL</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name></person-group><article-title>Heparan sulfate core proteins in cell-cell signaling</article-title><source>Annu Rev Genet</source><year>2003</year><volume>37</volume><fpage>461</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">14616070</pub-id><pub-id pub-id-type="doi">10.1146/annurev.genet.37.061103.090226</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hacker</surname><given-names>U</given-names></name><name><surname>Nybakken</surname><given-names>K</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Heparan sulphate proteoglycans: the sweet side of development</article-title><source>Nat Rev Mol Cell Biol</source><year>2005</year><volume>6</volume><fpage>530</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">16072037</pub-id><pub-id pub-id-type="doi">10.1038/nrm1681</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>K</given-names></name><name><surname>Lopez-Burks</surname><given-names>M</given-names></name><name><surname>Sanchez-Duran</surname><given-names>JA</given-names></name><name><surname>Korc</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells</article-title><source>J Cell Biol</source><year>2005</year><volume>171</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">16286510</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200508010</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aikawa</surname><given-names>T</given-names></name><name><surname>Whipple</surname><given-names>CA</given-names></name><name><surname>Lopez</surname><given-names>ME</given-names></name><name><surname>Gunn</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name><name><surname>Korc</surname><given-names>M</given-names></name></person-group><article-title>Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells</article-title><source>J Clin Invest</source><year>2008</year><volume>118</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">18064304</pub-id><pub-id pub-id-type="doi">10.1172/JCI32412</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karthikeyan</surname><given-names>L</given-names></name><name><surname>Maurel</surname><given-names>P</given-names></name><name><surname>Rauch</surname><given-names>U</given-names></name><name><surname>Margolis</surname><given-names>RK</given-names></name><name><surname>Margolis</surname><given-names>RU</given-names></name></person-group><article-title>Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican</article-title><source>Biochem Biophys Res Commun</source><year>1992</year><volume>188</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">1417860</pub-id><pub-id pub-id-type="doi">10.1016/0006-291X(92)92398-H</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karthikeyan</surname><given-names>L</given-names></name><name><surname>Flad</surname><given-names>M</given-names></name><name><surname>Engel</surname><given-names>M</given-names></name><name><surname>Meyer-Puttlitz</surname><given-names>B</given-names></name><name><surname>Margolis</surname><given-names>RU</given-names></name><name><surname>Margolis</surname><given-names>RK</given-names></name></person-group><article-title>Immunocytochemical and <italic>in situ </italic>hybridization studies of the heparan sulfate proteoglycan, glypican, in nervous tissue</article-title><source>J Cell Sci</source><year>1994</year><volume>107</volume><fpage>3213</fpage><lpage>3222</lpage><pub-id pub-id-type="pmid">7699018</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stipp</surname><given-names>CS</given-names></name><name><surname>Litwack</surname><given-names>ED</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation</article-title><source>J Cell Biol</source><year>1994</year><volume>124</volume><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">8294498</pub-id><pub-id pub-id-type="doi">10.1083/jcb.124.1.149</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litwack</surname><given-names>ED</given-names></name><name><surname>Stipp</surname><given-names>CS</given-names></name><name><surname>Kumbasar</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system</article-title><source>J Neurosci</source><year>1994</year><volume>14</volume><fpage>3713</fpage><lpage>3724</lpage><pub-id pub-id-type="pmid">8207484</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>S</given-names></name><name><surname>Paine-Saunders</surname><given-names>S</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain</article-title><source>Dev Biol</source><year>1997</year><volume>190</volume><fpage>78</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9331333</pub-id><pub-id pub-id-type="doi">10.1006/dbio.1997.8690</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hagihara</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name></person-group><article-title>Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells</article-title><source>Dev Dyn</source><year>2000</year><volume>219</volume><fpage>353</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">11066092</pub-id><pub-id pub-id-type="doi">10.1002/1097-0177(2000)9999:9999&#x0003c;::AID-DVDY1059&#x0003e;3.0.CO;2-#</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name></person-group><article-title>K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney</article-title><source>J Cell Biol</source><year>1995</year><volume>130</volume><fpage>1207</fpage><lpage>1218</lpage><pub-id pub-id-type="pmid">7657705</pub-id><pub-id pub-id-type="doi">10.1083/jcb.130.5.1207</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litwack</surname><given-names>ED</given-names></name><name><surname>Ivins</surname><given-names>JK</given-names></name><name><surname>Kumbasar</surname><given-names>A</given-names></name><name><surname>Paine-Saunders</surname><given-names>S</given-names></name><name><surname>Stipp</surname><given-names>CS</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent</article-title><source>Dev Dyn</source><year>1998</year><volume>211</volume><fpage>72</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">9438425</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199801)211:1&#x0003c;72::AID-AJA7&#x0003e;3.0.CO;2-4</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivins</surname><given-names>JK</given-names></name><name><surname>Litwack</surname><given-names>ED</given-names></name><name><surname>Kumbasar</surname><given-names>A</given-names></name><name><surname>Stipp</surname><given-names>CS</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones</article-title><source>Dev Biol</source><year>1997</year><volume>184</volume><fpage>320</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">9133438</pub-id><pub-id pub-id-type="doi">10.1006/dbio.1997.8532</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RW</given-names></name></person-group><article-title>Mapping genes that modulate mouse brain development: a quantitative genetic approach</article-title><source>Results Probl Cell Differ</source><year>2000</year><volume>30</volume><fpage>21</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">10857184</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labarca</surname><given-names>C</given-names></name><name><surname>Paigen</surname><given-names>K</given-names></name></person-group><article-title>A simple, rapid, and sensitive DNA assay procedure</article-title><source>Anal Biochem</source><year>1980</year><volume>102</volume><fpage>344</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">6158890</pub-id><pub-id pub-id-type="doi">10.1016/0003-2697(80)90165-7</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inatani</surname><given-names>M</given-names></name><name><surname>Irie</surname><given-names>F</given-names></name><name><surname>Plump</surname><given-names>AS</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name></person-group><article-title>Mammalian brain morphogenesis and midline axon guidance require heparan sulfate</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>1044</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">14605369</pub-id><pub-id pub-id-type="doi">10.1126/science.1090497</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luxardi</surname><given-names>G</given-names></name><name><surname>Galli</surname><given-names>A</given-names></name><name><surname>Forlani</surname><given-names>S</given-names></name><name><surname>Lawson</surname><given-names>K</given-names></name><name><surname>Maina</surname><given-names>F</given-names></name><name><surname>Dono</surname><given-names>R</given-names></name></person-group><article-title>Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>352</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17107664</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.10.185</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kauffman</surname><given-names>SL</given-names></name></person-group><article-title>An autoradiographic study of the generation cycle in the ten-day mouse embryo neural tube</article-title><source>Exp Cell Res</source><year>1966</year><volume>42</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">5929575</pub-id><pub-id pub-id-type="doi">10.1016/0014-4827(66)90320-X</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gressens</surname><given-names>P</given-names></name><name><surname>Paindaveine</surname><given-names>B</given-names></name><name><surname>Hill</surname><given-names>JM</given-names></name><name><surname>Evrard</surname><given-names>P</given-names></name><name><surname>Brenneman</surname><given-names>DE</given-names></name></person-group><article-title>Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos</article-title><source>Eur J Neurosci</source><year>1998</year><volume>10</volume><fpage>1734</fpage><lpage>1742</lpage><pub-id pub-id-type="pmid">9751145</pub-id><pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00172.x</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ybot-Gonzalez</surname><given-names>P</given-names></name><name><surname>Copp</surname><given-names>AJ</given-names></name><name><surname>Greene</surname><given-names>ND</given-names></name></person-group><article-title>Expression pattern of glypican-4 suggests multiple roles during mouse development</article-title><source>Dev Dyn</source><year>2005</year><volume>233</volume><fpage>1013</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">15830372</pub-id><pub-id pub-id-type="doi">10.1002/dvdy.20383</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimogori</surname><given-names>T</given-names></name><name><surname>Banuchi</surname><given-names>V</given-names></name><name><surname>Ng</surname><given-names>HY</given-names></name><name><surname>Strauss</surname><given-names>JB</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name></person-group><article-title>Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>5639</fpage><lpage>5647</lpage><pub-id pub-id-type="pmid">15509764</pub-id><pub-id pub-id-type="doi">10.1242/dev.01428</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname><given-names>EE</given-names></name><name><surname>Garel</surname><given-names>S</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name></person-group><article-title>Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>1831</fpage><lpage>1844</lpage><pub-id pub-id-type="pmid">16613831</pub-id><pub-id pub-id-type="doi">10.1242/dev.02324</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monuki</surname><given-names>ES</given-names></name></person-group><article-title>The morphogen signaling network in forebrain development and holoprosencephaly</article-title><source>J Neuropathol Exp Neurol</source><year>2007</year><volume>66</volume><fpage>566</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">17620982</pub-id><pub-id pub-id-type="doi">10.1097/nen.0b013e3180986e1b</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basson</surname><given-names>MA</given-names></name><name><surname>Echevarria</surname><given-names>D</given-names></name><name><surname>Ahn</surname><given-names>CP</given-names></name><name><surname>Sudarov</surname><given-names>A</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name><name><surname>Mason</surname><given-names>IJ</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development</article-title><source>Development</source><year>2008</year><volume>135</volume><fpage>889</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">18216176</pub-id><pub-id pub-id-type="doi">10.1242/dev.011569</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selleck</surname><given-names>SB</given-names></name></person-group><article-title>Shedding light on the distinct functions of proteoglycans</article-title><source>Sci STKE</source><year>2006</year><volume>2006</volume><fpage>pe17</fpage><pub-id pub-id-type="pmid">16595733</pub-id><pub-id pub-id-type="doi">10.1126/stke.3292006pe17</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Fibroblast growth factors</article-title><source>Genome Biol</source><year>2001</year><volume>2</volume><fpage>REVIEWS3005</fpage><pub-id pub-id-type="pmid">11276432</pub-id><pub-id pub-id-type="doi">10.1186/gb-2001-2-3-reviews3005</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeHamer</surname><given-names>MK</given-names></name><name><surname>Guevara</surname><given-names>JL</given-names></name><name><surname>Hannon</surname><given-names>K</given-names></name><name><surname>Olwin</surname><given-names>BB</given-names></name><name><surname>Calof</surname><given-names>AL</given-names></name></person-group><article-title>Genesis of olfactory receptor neurons <italic>in vitro </italic>: regulation of progenitor cell divisions by fibroblast growth factors</article-title><source>Neuron</source><year>1994</year><volume>13</volume><fpage>1083</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">7946347</pub-id><pub-id pub-id-type="doi">10.1016/0896-6273(94)90047-7</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gritti</surname><given-names>A</given-names></name><name><surname>Frolichsthal-Schoeller</surname><given-names>P</given-names></name><name><surname>Galli</surname><given-names>R</given-names></name><name><surname>Parati</surname><given-names>EA</given-names></name><name><surname>Cova</surname><given-names>L</given-names></name><name><surname>Pagano</surname><given-names>SF</given-names></name><name><surname>Bjornson</surname><given-names>CR</given-names></name><name><surname>Vescovi</surname><given-names>AL</given-names></name></person-group><article-title>Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>3287</fpage><lpage>3297</lpage><pub-id pub-id-type="pmid">10212288</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaccarino</surname><given-names>FM</given-names></name><name><surname>Schwartz</surname><given-names>ML</given-names></name><name><surname>Raballo</surname><given-names>R</given-names></name><name><surname>Nilsen</surname><given-names>J</given-names></name><name><surname>Rhee</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Doetschman</surname><given-names>T</given-names></name><name><surname>Coffin</surname><given-names>JD</given-names></name><name><surname>Wyland</surname><given-names>JJ</given-names></name><name><surname>Hung</surname><given-names>YT</given-names></name></person-group><article-title>Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis</article-title><source>Nat Neurosci</source><year>1999</year><volume>2</volume><fpage>246</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">10195217</pub-id><pub-id pub-id-type="doi">10.1038/6350</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maric</surname><given-names>D</given-names></name><name><surname>Maric</surname><given-names>I</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Barker</surname><given-names>JL</given-names></name></person-group><article-title>Prospective cell sorting of embryonic rat neural stem cells and neuronal and glial progenitors reveals selective effects of basic fibroblast growth factor and epidermal growth factor on self-renewal and differentiation</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>240</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">12514221</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohkubo</surname><given-names>Y</given-names></name><name><surname>Uchida</surname><given-names>AO</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Vaccarino</surname><given-names>FM</given-names></name></person-group><article-title>Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>6057</fpage><lpage>6069</lpage><pub-id pub-id-type="pmid">15240797</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1140-04.2004</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Nowakowski</surname><given-names>RS</given-names></name><name><surname>Vaccarino</surname><given-names>FM</given-names></name></person-group><article-title>Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone</article-title><source>Dev Neurosci</source><year>2004</year><volume>26</volume><fpage>181</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">15711059</pub-id><pub-id pub-id-type="doi">10.1159/000082136</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawauchi</surname><given-names>S</given-names></name><name><surname>Shou</surname><given-names>J</given-names></name><name><surname>Santos</surname><given-names>R</given-names></name><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name><name><surname>Mason</surname><given-names>I</given-names></name><name><surname>Calof</surname><given-names>AL</given-names></name></person-group><article-title>Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>5211</fpage><lpage>5223</lpage><pub-id pub-id-type="pmid">16267092</pub-id><pub-id pub-id-type="doi">10.1242/dev.02143</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maric</surname><given-names>D</given-names></name><name><surname>Fiorio Pla</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Barker</surname><given-names>JL</given-names></name></person-group><article-title>Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>1836</fpage><lpage>1852</lpage><pub-id pub-id-type="pmid">17314281</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5141-06.2007</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saarimaki-Vire</surname><given-names>J</given-names></name><name><surname>Peltopuro</surname><given-names>P</given-names></name><name><surname>Lahti</surname><given-names>L</given-names></name><name><surname>Naserke</surname><given-names>T</given-names></name><name><surname>Blak</surname><given-names>AA</given-names></name><name><surname>Vogt Weisenhorn</surname><given-names>DM</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name></person-group><article-title>Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>8581</fpage><lpage>8592</lpage><pub-id pub-id-type="pmid">17687036</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0192-07.2007</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>RE</given-names></name><name><surname>Pellicano</surname><given-names>F</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name></person-group><article-title>Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen-activated protein kinase activation</article-title><source>J Neurochem</source><year>2007</year><volume>100</volume><fpage>1565</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">17181553</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linkhart</surname><given-names>TA</given-names></name><name><surname>Clegg</surname><given-names>CH</given-names></name><name><surname>Hauschka</surname><given-names>SD</given-names></name></person-group><article-title>Control of mouse myoblast commitment to terminal differentiation by mitogens</article-title><source>J Supramol Struct</source><year>1980</year><volume>14</volume><fpage>483</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">6454029</pub-id><pub-id pub-id-type="doi">10.1002/jss.400140407</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clegg</surname><given-names>CH</given-names></name><name><surname>Linkhart</surname><given-names>TA</given-names></name><name><surname>Olwin</surname><given-names>BB</given-names></name><name><surname>Hauschka</surname><given-names>SD</given-names></name></person-group><article-title>Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor</article-title><source>J Cell Biol</source><year>1987</year><volume>105</volume><fpage>949</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">3624313</pub-id><pub-id pub-id-type="doi">10.1083/jcb.105.2.949</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>I</given-names></name><name><surname>Chambers</surname><given-names>D</given-names></name><name><surname>Shamim</surname><given-names>H</given-names></name><name><surname>Walshe</surname><given-names>J</given-names></name><name><surname>Irving</surname><given-names>C</given-names></name></person-group><article-title>Regulation and function of FGF8 in patterning of midbrain and anterior hindbrain</article-title><source>Biochem Cell Biol</source><year>2000</year><volume>78</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">11103948</pub-id><pub-id pub-id-type="doi">10.1139/bcb-78-5-577</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>CL</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>2633</fpage><lpage>2644</lpage><pub-id pub-id-type="pmid">12736208</pub-id><pub-id pub-id-type="doi">10.1242/dev.00487</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cholfin</surname><given-names>JA</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name></person-group><article-title>Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2</article-title><source>J Comp Neurol</source><year>2008</year><volume>509</volume><fpage>144</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">18459137</pub-id><pub-id pub-id-type="doi">10.1002/cne.21709</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lawshe</surname><given-names>A</given-names></name><name><surname>MacArthur</surname><given-names>CA</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Genomic structure, mapping, activity and expression of fibroblast growth factor 17</article-title><source>Mech Dev</source><year>1999</year><volume>83</volume><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">10381577</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(99)00034-9</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1833</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">10751172</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name><name><surname>Bromleigh</surname><given-names>C</given-names></name><name><surname>Lao</surname><given-names>Z</given-names></name><name><surname>Niswander</surname><given-names>LA</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name></person-group><article-title>FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>6175</fpage><lpage>6185</lpage><pub-id pub-id-type="pmid">14602678</pub-id><pub-id pub-id-type="doi">10.1242/dev.00845</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>A</given-names></name><name><surname>Roure</surname><given-names>A</given-names></name><name><surname>Zeller</surname><given-names>R</given-names></name><name><surname>Dono</surname><given-names>R</given-names></name></person-group><article-title>Glypican 4 modulates FGF signalling and regulates dorsoventral forebrain patterning in <italic>Xenopus </italic>embryos</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>4919</fpage><lpage>4929</lpage><pub-id pub-id-type="pmid">12930779</pub-id><pub-id pub-id-type="doi">10.1242/dev.00706</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ford-Perriss</surname><given-names>M</given-names></name><name><surname>Guimond</surname><given-names>SE</given-names></name><name><surname>Greferath</surname><given-names>U</given-names></name><name><surname>Kita</surname><given-names>M</given-names></name><name><surname>Grobe</surname><given-names>K</given-names></name><name><surname>Habuchi</surname><given-names>H</given-names></name><name><surname>Kimata</surname><given-names>K</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Turnbull</surname><given-names>JE</given-names></name></person-group><article-title>Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling</article-title><source>Glycobiology</source><year>2002</year><volume>12</volume><fpage>721</fpage><lpage>727</lpage><pub-id pub-id-type="pmid">12460940</pub-id><pub-id pub-id-type="doi">10.1093/glycob/cwf072</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreuger</surname><given-names>J</given-names></name><name><surname>Spillmann</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>JP</given-names></name><name><surname>Lindahl</surname><given-names>U</given-names></name></person-group><article-title>Interactions between heparan sulfate and proteins: the concept of specificity</article-title><source>J Cell Biol</source><year>2006</year><volume>174</volume><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">16880267</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200604035</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>JR</given-names></name><name><surname>Schuksz</surname><given-names>M</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name></person-group><article-title>Heparan sulphate proteoglycans fine-tune mammalian physiology</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>1030</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">17460664</pub-id><pub-id pub-id-type="doi">10.1038/nature05817</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>HH</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Xiang</surname><given-names>YY</given-names></name><name><surname>Filmus</surname><given-names>J</given-names></name></person-group><article-title>The loss of glypican-3 induces alterations in Wnt signaling</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>2116</fpage><lpage>2125</lpage><pub-id pub-id-type="pmid">15537637</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M410090200</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capurro</surname><given-names>MI</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Jia</surname><given-names>A</given-names></name><name><surname>Filmus</surname><given-names>J</given-names></name></person-group><article-title>Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding</article-title><source>Dev Cell</source><year>2008</year><volume>14</volume><fpage>700</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">18477453</pub-id><pub-id pub-id-type="doi">10.1016/j.devcel.2008.03.006</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuchi-Shimogori</surname><given-names>T</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name></person-group><article-title>Neocortex patterning by the secreted signaling molecule FGF8</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>1071</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">11567107</pub-id><pub-id pub-id-type="doi">10.1126/science.1064252</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Mishina</surname><given-names>Y</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><article-title>BMP signaling is required locally to pattern the dorsal telencephalic midline</article-title><source>Neuron</source><year>2002</year><volume>35</volume><fpage>1029</fpage><lpage>1041</lpage><pub-id pub-id-type="pmid">12354394</pub-id><pub-id pub-id-type="doi">10.1016/S0896-6273(02)00900-5</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>JM</given-names></name></person-group><article-title>Unraveling the molecular pathways that regulate early telencephalon development</article-title><source>Curr Top Dev Biol</source><year>2005</year><volume>69</volume><fpage>17</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">16243595</pub-id><pub-id pub-id-type="doi">10.1016/S0070-2153(05)69002-3</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Fishell</surname><given-names>G</given-names></name></person-group><article-title>The genetics of early telencephalon patterning: some assembly required</article-title><source>Nat Rev Neurosci</source><year>2008</year><volume>9</volume><fpage>678</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">19143049</pub-id><pub-id pub-id-type="doi">10.1038/nrn2463</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>CJ</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Pleasure</surname><given-names>SJ</given-names></name></person-group><article-title>Neuronal production and precursor proliferation defects in the neocortex of mice with loss of function in the canonical Wnt signaling pathway</article-title><source>Neuroscience</source><year>2006</year><volume>142</volume><fpage>1119</fpage><lpage>1131</lpage><pub-id pub-id-type="pmid">16920270</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.07.007</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayhurst</surname><given-names>M</given-names></name><name><surname>Gore</surname><given-names>BB</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><article-title>Ongoing sonic hedgehog signaling is required for dorsal midline formation in the developing forebrain</article-title><source>Dev Neurobiol</source><year>2008</year><volume>68</volume><fpage>83</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">17948241</pub-id><pub-id pub-id-type="doi">10.1002/dneu.20576</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>McConnell</surname><given-names>SK</given-names></name></person-group><article-title>FGF signaling through FGFR1 is required for olfactory bulb morphogenesis</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>1101</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">12571102</pub-id><pub-id pub-id-type="doi">10.1242/dev.00334</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garel</surname><given-names>S</given-names></name><name><surname>Huffman</surname><given-names>KJ</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name></person-group><article-title>Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>1903</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">12642494</pub-id><pub-id pub-id-type="doi">10.1242/dev.00416</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Woodbury</surname><given-names>A</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name><name><surname>Grobe</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>4933</fpage><lpage>4944</lpage><pub-id pub-id-type="pmid">17107998</pub-id><pub-id pub-id-type="doi">10.1242/dev.02679</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grobe</surname><given-names>K</given-names></name><name><surname>Inatani</surname><given-names>M</given-names></name><name><surname>Pallerla</surname><given-names>SR</given-names></name><name><surname>Castagnola</surname><given-names>J</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name></person-group><article-title>Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>3777</fpage><lpage>3786</lpage><pub-id pub-id-type="pmid">16020517</pub-id><pub-id pub-id-type="doi">10.1242/dev.01935</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RW</given-names></name><name><surname>Herrup</surname><given-names>K</given-names></name></person-group><article-title>The control of neuron number</article-title><source>Annu Rev Neurosci</source><year>1988</year><volume>11</volume><fpage>423</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">3284447</pub-id><pub-id pub-id-type="doi">10.1146/annurev.ne.11.030188.002231</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>F</given-names></name><name><surname>Christians</surname><given-names>JK</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Rhind</surname><given-names>S</given-names></name><name><surname>Verma</surname><given-names>V</given-names></name><name><surname>Davison</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Denny</surname><given-names>P</given-names></name><name><surname>Keightley</surname><given-names>PD</given-names></name></person-group><article-title>Regulatory variation at glypican-3 underlies a major growth QTL in mice</article-title><source>PLoS Biol</source><year>2005</year><volume>3</volume><fpage>e135</fpage><pub-id pub-id-type="pmid">15799711</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0030135</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiao</surname><given-names>E</given-names></name><name><surname>Fisher</surname><given-names>P</given-names></name><name><surname>Crisponi</surname><given-names>L</given-names></name><name><surname>Deiana</surname><given-names>M</given-names></name><name><surname>Dragatsis</surname><given-names>I</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Pilia</surname><given-names>G</given-names></name><name><surname>Efstratiadis</surname><given-names>A</given-names></name></person-group><article-title>Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling</article-title><source>Dev Biol</source><year>2002</year><volume>243</volume><fpage>185</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">11846487</pub-id><pub-id pub-id-type="doi">10.1006/dbio.2001.0554</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crickmore</surname><given-names>MA</given-names></name><name><surname>Mann</surname><given-names>RS</given-names></name></person-group><article-title>Hox control of morphogen mobility and organ development through regulation of glypican expression</article-title><source>Development</source><year>2007</year><volume>134</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">17166918</pub-id><pub-id pub-id-type="doi">10.1242/dev.02737</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baena-Lopez</surname><given-names>LA</given-names></name><name><surname>Rodriguez</surname><given-names>I</given-names></name><name><surname>Baonza</surname><given-names>A</given-names></name></person-group><article-title>The tumor suppressor genes dachsous and fat modulate different signalling pathways by regulating dally and dally-like</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>9645</fpage><lpage>9650</lpage><pub-id pub-id-type="pmid">18621676</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0803747105</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawson</surname><given-names>JM</given-names></name><name><surname>Dimitroff</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>KG</given-names></name><name><surname>Rawson</surname><given-names>JM</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Van Vactor</surname><given-names>D</given-names></name><name><surname>Selleck</surname><given-names>SB</given-names></name></person-group><article-title>The heparan sulfate proteoglycans Dally-like and Syndecan have distinct functions in axon guidance and visual-system assembly in <italic>Drosophila</italic></article-title><source>Curr Biol</source><year>2005</year><volume>15</volume><fpage>833</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">15886101</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2005.03.039</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>PT</given-names></name></person-group><article-title>Glycobiology of the synapse</article-title><source>Glycobiology</source><year>2002</year><volume>12</volume><fpage>1R</fpage><lpage>7R</lpage><pub-id pub-id-type="pmid">11825880</pub-id><pub-id pub-id-type="doi">10.1093/glycob/12.1.1R</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y</given-names></name></person-group><article-title>Glycobiology of the synapse: the role of glycans in the formation, maturation, and modulation of synapses</article-title><source>Biochim Biophys Acta</source><year>2002</year><volume>1573</volume><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">12417420</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ethell</surname><given-names>IM</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name></person-group><article-title>Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons</article-title><source>J Cell Biol</source><year>1999</year><volume>144</volume><fpage>575</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">9971750</pub-id><pub-id pub-id-type="doi">10.1083/jcb.144.3.575</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>KG</given-names></name><name><surname>Tenney</surname><given-names>AP</given-names></name><name><surname>Ghose</surname><given-names>A</given-names></name><name><surname>Duckworth</surname><given-names>AM</given-names></name><name><surname>Higashi</surname><given-names>ME</given-names></name><name><surname>Parfitt</surname><given-names>K</given-names></name><name><surname>Marcu</surname><given-names>O</given-names></name><name><surname>Heslip</surname><given-names>TR</given-names></name><name><surname>Marsh</surname><given-names>JL</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name><name><surname>Flanagan</surname><given-names>JG</given-names></name><name><surname>Van Vactor</surname><given-names>D</given-names></name></person-group><article-title>The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development</article-title><source>Neuron</source><year>2006</year><volume>49</volume><fpage>517</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">16476662</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.026</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuhara</surname><given-names>N</given-names></name><name><surname>Howitt</surname><given-names>JA</given-names></name><name><surname>Hussain</surname><given-names>SA</given-names></name><name><surname>Hohenester</surname><given-names>E</given-names></name></person-group><article-title>Structural and functional analysis of slit and heparin binding to immunoglobulin-like domains 1 and 2 of <italic>Drosophila </italic>Robo</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>16226</fpage><lpage>16234</lpage><pub-id pub-id-type="pmid">18359766</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M800688200</pub-id></citation></ref><ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>KG</given-names></name><name><surname>Ghose</surname><given-names>A</given-names></name><name><surname>Epstein</surname><given-names>E</given-names></name><name><surname>Lincecum</surname><given-names>J</given-names></name><name><surname>O'Connor</surname><given-names>MB</given-names></name><name><surname>Van Vactor</surname><given-names>D</given-names></name></person-group><article-title>Axonal heparan sulfate proteoglycans regulate the distribution and efficiency of the repellent slit during midline axon guidance</article-title><source>Curr Biol</source><year>2004</year><volume>14</volume><fpage>499</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">15043815</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2004.02.005</pub-id></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potkin</surname><given-names>SG</given-names></name><name><surname>Turner</surname><given-names>JA</given-names></name><name><surname>Guffanti</surname><given-names>G</given-names></name><name><surname>Lakatos</surname><given-names>A</given-names></name><name><surname>Fallon</surname><given-names>JH</given-names></name><name><surname>Nguyen</surname><given-names>DD</given-names></name><name><surname>Mathalon</surname><given-names>D</given-names></name><name><surname>Ford</surname><given-names>J</given-names></name><name><surname>Lauriello</surname><given-names>J</given-names></name><name><surname>Macciardi</surname><given-names>F</given-names></name></person-group><article-title>A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype</article-title><source>Schizophr Bull</source><year>2009</year><volume>35</volume><fpage>96</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">19023125</pub-id><pub-id pub-id-type="doi">10.1093/schbul/sbn155</pub-id></citation></ref><ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Norton</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>H</given-names></name><name><surname>Peirce</surname><given-names>T</given-names></name><name><surname>Moskvina</surname><given-names>V</given-names></name><name><surname>Nikolov</surname><given-names>I</given-names></name><name><surname>Hamshere</surname><given-names>M</given-names></name><name><surname>Carroll</surname><given-names>L</given-names></name><name><surname>Georgieva</surname><given-names>L</given-names></name><name><surname>Dwyer</surname><given-names>S</given-names></name><name><surname>Holmans</surname><given-names>P</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>Spencer</surname><given-names>CC</given-names></name><name><surname>Howie</surname><given-names>B</given-names></name><name><surname>Leung</surname><given-names>HT</given-names></name><name><surname>Giegling</surname><given-names>I</given-names></name><name><surname>Hartmann</surname><given-names>AM</given-names></name><name><surname>M&#x000f6;ller</surname><given-names>HJ</given-names></name><name><surname>Morris</surname><given-names>DW</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Hoffmann</surname><given-names>P</given-names></name><name><surname>Propping</surname><given-names>P</given-names></name><name><surname>Vasilescu</surname><given-names>C</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Rietschel</surname><given-names>M</given-names></name><name><surname>Zammit</surname><given-names>S</given-names></name><name><surname>Schumacher</surname><given-names>J</given-names></name><name><surname>Quinn</surname><given-names>EM</given-names></name><name><surname>Schulze</surname><given-names>TG</given-names></name><etal></etal></person-group><article-title>Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2</article-title><source>Mol Psychiatry</source><year>2009</year><volume>14</volume><fpage>30</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">18813210</pub-id><pub-id pub-id-type="doi">10.1038/mp.2008.108</pub-id></citation></ref><ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steen</surname><given-names>RG</given-names></name><name><surname>Mull</surname><given-names>C</given-names></name><name><surname>McClure</surname><given-names>R</given-names></name><name><surname>Hamer</surname><given-names>RM</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><article-title>Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies</article-title><source>Br J Psychiatry</source><year>2006</year><volume>188</volume><fpage>510</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">16738340</pub-id><pub-id pub-id-type="doi">10.1192/bjp.188.6.510</pub-id></citation></ref><ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>KE</given-names></name><name><surname>Friedman</surname><given-names>L</given-names></name><name><surname>Wise</surname><given-names>A</given-names></name><name><surname>Schulz</surname><given-names>SC</given-names></name></person-group><article-title>Meta-analysis of brain and cranial size in schizophrenia</article-title><source>Schizophr Res</source><year>1996</year><volume>22</volume><fpage>197</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">9000317</pub-id><pub-id pub-id-type="doi">10.1016/S0920-9964(96)00076-X</pub-id></citation></ref><ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Moss</surname><given-names>JE</given-names></name><name><surname>Hurtley</surname><given-names>SM</given-names></name><name><surname>Beddington</surname><given-names>RS</given-names></name></person-group><article-title>Capturing genes encoding membrane and secreted proteins important for mouse development</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>6592</fpage><lpage>6596</lpage><pub-id pub-id-type="pmid">7604039</pub-id><pub-id pub-id-type="doi">10.1073/pnas.92.14.6592</pub-id></citation></ref><ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>KJ</given-names></name><name><surname>Pinson</surname><given-names>KI</given-names></name><name><surname>Kelly</surname><given-names>OG</given-names></name><name><surname>Brennan</surname><given-names>J</given-names></name><name><surname>Zupicich</surname><given-names>J</given-names></name><name><surname>Scherz</surname><given-names>P</given-names></name><name><surname>Leighton</surname><given-names>PA</given-names></name><name><surname>Goodrich</surname><given-names>LV</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Avery</surname><given-names>BJ</given-names></name><name><surname>Tate</surname><given-names>P</given-names></name><name><surname>Dill</surname><given-names>K</given-names></name><name><surname>Pangilinan</surname><given-names>E</given-names></name><name><surname>Wakenight</surname><given-names>P</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Skarnes</surname><given-names>WC</given-names></name></person-group><article-title>Functional analysis of secreted and transmembrane proteins critical to mouse development</article-title><source>Nat Genet</source><year>2001</year><volume>28</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">11431694</pub-id><pub-id pub-id-type="doi">10.1038/90074</pub-id></citation></ref><ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination</article-title><source>Nat Genet</source><year>1998</year><volume>18</volume><fpage>136</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">9462741</pub-id><pub-id pub-id-type="doi">10.1038/ng0298-136</pub-id></citation></ref><ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maretto</surname><given-names>S</given-names></name><name><surname>Cordenonsi</surname><given-names>M</given-names></name><name><surname>Dupont</surname><given-names>S</given-names></name><name><surname>Braghetta</surname><given-names>P</given-names></name><name><surname>Broccoli</surname><given-names>V</given-names></name><name><surname>Hassan</surname><given-names>AB</given-names></name><name><surname>Volpin</surname><given-names>D</given-names></name><name><surname>Bressan</surname><given-names>GM</given-names></name><name><surname>Piccolo</surname><given-names>S</given-names></name></person-group><article-title>Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>3299</fpage><lpage>3304</lpage><pub-id pub-id-type="pmid">12626757</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0434590100</pub-id></citation></ref><ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mombaerts</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name><name><surname>Chao</surname><given-names>SK</given-names></name><name><surname>Nemes</surname><given-names>A</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Edmondson</surname><given-names>J</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name></person-group><article-title>Visualizing an olfactory sensory map</article-title><source>Cell</source><year>1996</year><volume>87</volume><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">8929536</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81387-2</pub-id></citation></ref><ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>DG</given-names></name><name><surname>Nieto</surname><given-names>MA</given-names></name></person-group><article-title>Detection of messenger RNA by <italic>in situ </italic>hybridization to tissue sections and whole mounts</article-title><source>Methods Enzymol</source><year>1993</year><volume>225</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">8231863</pub-id><comment>full_text</comment></citation></ref><ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Itaranta</surname><given-names>P</given-names></name><name><surname>Yagi</surname><given-names>A</given-names></name><name><surname>Vainio</surname><given-names>S</given-names></name></person-group><article-title>Expression of Sprouty genes 1, 2 and 4 during mouse organogenesis</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">11731251</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00526-3</pub-id></citation></ref><ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>RJ</given-names></name><name><surname>Eblaghie</surname><given-names>MC</given-names></name><name><surname>Keyse</surname><given-names>SM</given-names></name><name><surname>Morriss-Kay</surname><given-names>GM</given-names></name></person-group><article-title>Expression of the ERK-specific MAP kinase phosphatase PYST1/MKP3 in mouse embryos during morphogenesis and early organogenesis</article-title><source>Mech Dev</source><year>2002</year><volume>113</volume><fpage>193</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">11960712</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(02)00024-2</pub-id></citation></ref><ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodrich</surname><given-names>LV</given-names></name><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Milenkovic</surname><given-names>L</given-names></name><name><surname>McMahon</surname><given-names>JA</given-names></name><name><surname>Scott</surname><given-names>MP</given-names></name></person-group><article-title>Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>301</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">8595881</pub-id><pub-id pub-id-type="doi">10.1101/gad.10.3.301</pub-id></citation></ref><ref id="B109"><citation citation-type="other"><article-title>Image J</article-title><ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/"/></citation></ref><ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Currle</surname><given-names>DS</given-names></name><name><surname>Hu</surname><given-names>JS</given-names></name><name><surname>Barkovich</surname><given-names>AJ</given-names></name><name><surname>Monuki</surname><given-names>ES</given-names></name></person-group><article-title>Central roles of the roof plate in telencephalic development and holoprosencephaly</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>7640</fpage><lpage>7649</lpage><pub-id pub-id-type="pmid">16855091</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0714-06.2006</pub-id></citation></ref><ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Currle</surname><given-names>DS</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Monuki</surname><given-names>ES</given-names></name></person-group><article-title>Direct and indirect roles of central nervous system dorsal midline cells in choroid plexus epithelia formation</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>3549</fpage><lpage>3559</lpage><pub-id pub-id-type="pmid">15975937</pub-id><pub-id pub-id-type="doi">10.1242/dev.01915</pub-id></citation></ref><ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></citation></ref><ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>JM</given-names></name></person-group><article-title>The bicinchoninic acid (BCA) assay for protein quantitation</article-title><source>Methods Mol Biol</source><year>1994</year><volume>32</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7951748</pub-id></citation></ref><ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herndon</surname><given-names>ME</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group><article-title>A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system</article-title><source>Neuron</source><year>1990</year><volume>4</volume><fpage>949</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">2361016</pub-id><pub-id pub-id-type="doi">10.1016/0896-6273(90)90148-9</pub-id></citation></ref></ref-list></back></article> 